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Zusammenfassung
Zielstellung: Maßnahmen zur Behandlung krankheitsbezogener Mangelerna¨hrung sind
selten und wenig praktikabel. In dieser Studie wird untersucht inwiefern die Energie-
und Proteinaufnahme von Patienten mit Mangelerna¨hrungsrisiko durch eine individuel-
le Erna¨hrungsbetreuung gesteigert werden kann und sich dies auf klinische Parameter
und die Lebensqualita¨t auswirkt.
Methoden: Eine randomisierte kontrollierte Interventionsstudie wurde durchgefu¨hrt.
Risikopatienten, definiert mittels ”Nutritional Risk Screening 2002”, erhielten entwe-
der eine individualisierte Erna¨hrungstherapie (Interventionsgruppe) oder die Standard-
betreuung (Kontrollgruppe). Ein engmaschiger Algorithmus wurde angewandt, um den
ta¨glichen individuellen Bedarf an Energie und Protein zu decken. Der Erna¨hrungsstatus,
das Ko¨rpergewicht und Serum-Vitaminkonzentrationen wurden bestimmt. Die Lebens-
qualita¨t wurde mittels SF-36-Fragebogen erfasst sowie Komplikationen und die Wieder-
eintrittsrate registriert.
Ergebnisse: Die Erna¨hrungsinterventionen fu¨hrten zu ho¨heren Aufnahmen (Mittelwert
(Standardabweichung)) an Energie (1553 (341) kcal vs. 1115 (381) kcal, p<0.001) und
Protein (65.4 (16.4) g vs. 43.9 (17.2) g, p<0.001). Die AONVA mit Messwiederholung
ergab einen hochsignifikanten Interventionseffekt auf Protein- und Energieaufnahme. In-
terventionspatienten behielten im Vergleich zur Kontrollgruppe ihr Ko¨rpergewicht (0.0
(2.9) kg vs. -1.4 (3.2) kg, p=0.008). Positive Effekte auf Serum-Vitamin C-Konzentration
(46.7 (26.7) µmol/l vs. 34.1 (24.2) µmol/l, p=0.010), SF-36 Summenfunktionsskala (37
(11) % vs. 32 (9) %, p=0.030), Anzahl an Komplikationen (4/66 vs. 13/66, p=0.035),
Anzahl Antibiotikatherapien (1/66 vs. 8/66, p=0.033) und Wiedereintrittsraten (17/64
vs. 28/61, p=0.027) wurden ermittelt. Kein Unterschied trat bei Austritts-Ko¨rperge-
wicht, Hospitalisationsdauer und Mortalita¨t auf.
Schlussfolgerung: Mangelerna¨hrte Patienten profitieren hinsichtlich ihres Erna¨hrungs-
status, der Funktionalita¨t und der Lebensqualita¨t von einer Erna¨hrungstherapie. Sie be-
kommen weniger Komplikationen, beno¨tigen weniger Antibiotika-Therapien und werden
seltener rehospitalisiert.
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Abstract
Rationale: Nutritional strategies to treat malnutrition are rare and lack practicabil-
ity in the hospital setting. This study aims at providing nutritional risk patients with
individual nutrition care in order to raise energy and protein intake and investigate nu-
tritional and clinical outcome parameters.
Methods: A randomized controlled intervention study was conducted. Risk patients
defined by Nutritional Risk Screening 2002 were either randomised to individualised nu-
tritional support (intervention group) or standard hospital care (control group). A tight
algorithm was applied to meet daily individual requirements of energy and protein. The
nutritional status, body weight and serum vitamin levels were determined. Quality of
life was assessed (SF-36 questionnaire) and complications and readmission rates recorded.
Results: The nutritional interventions led to higher intakes (mean (standard deviation))
in energy (1553 (341) kcal vs. 1115 (381) kcal, p<0.001) and protein (65.4 (16.4) g vs.
43.9 (17.2) g, p<0.001). Repeated measure AONVA revealed a highly significant effect
on protein and energy intake. Intervention patients kept their body weight in compari-
son to control patients (0.0 (2.9) kg vs. -1.4 (3.2) kg, p=0.008). Positive effects on serum
ascorbic acid level (46.7 (26.7) µmol/l vs. 34.1 (24.2) µmol/l, p=0.010), SF-36 function
summary scale (37 (11) % vs. 32 (9) %, p=0.030), number of complications (4/66 vs.
13/66, p=0.035), antibiotics therapy (1/66 vs. 8/66, p=0.033) and readmissions (17/64
vs. 28/61, p=0.027) were recorded. No differences in discharge body weight, length of
stay and mortality were found.
Conclusions: Malnourished patients profit in terms of their nutritional status, func-
tionality and quality of life from nutritional support. They gain fewer complications,
need fewer antibiotics and are less often rehospitalised.
v

Preface
Does malnutrition matter? Globally, malnutrition is still the number one health risk
responsible for disease and death. The most recent estimate of the Food and Agriculture
Organisation (FAO) from October 2010 says that 925 billion people are undernourished,
i.e. 13 % of the world population [1]. The vast majority of them live in developing
countries, i.e. sub-Saharan Africa and Asia, and children are especially affected. It is
due to chronic food deficits of various reasons, that energy, protein and micronutrient
deficiencies are widely spread. As Africa is far away, most people reduce hunger and
starvation to this continent. However, the FAO report also shows that about 19 billion
people suffer from hunger in developed countries [1]. Since a lack of food as reason for
undernutrition is unlikely in an economically successful region that leaves the obvious
question: How did this come about then?
Historical research revealed that as late as the early 19th century poverty and chronic
hunger dominated in many parts all over Europe [2]. According to the first epidemiologi-
cal data of today’s French region Alsace, a malnutrition prevalence of 16 % was recorded
especially among the non-privileged population like tailors, fishermen and the unem-
ployed [3]. Criteria to define malnutrition were mainly clinical signs of single micronu-
trient deficiencies. Until the middle of the 20th century food supplies became adequate
and primary malnutrition declined to a minimum after the Second World War in Eu-
rope [4]. In Switzerland, post-war investigations initiated by governmental institutions
revealed an impaired micronutrient status in people living isolated up in the mountains.
However, the total energy intake was sufficient [5]. A suboptimal diet related to a change
from self-supply to dependence on foreign products and ”an erroneously assumption that
a nutrition rich in proteins is complete already”, was considered as reason. In an inter-
vention trial in 1957, children were provided with ground nuts (source of thiamine) and
one of the first Swiss functional foods (a multivitamin Ovomaltine® bar) additionally
to the normal food. In comparison to earlier data of the same population, the study
showed a reduction of single nutrient deficiencies resulting in less school absences due
to illness [6]. Since post-war time the further development of food supply, storage and
trade widely led to the disappearance of macro- and micronutrient deficiencies due to
lack of food. In contrast, overnutrition dominates with an epidemic extent in present
generations [7]. However, further economic and social developments brought back his-
toric reasons for malnutrition in certain situations. The consumption of cheap, processed
and low nutrient food may lead to partial undernutrition today, especially in low-income
families or alcohol/drug addicts [8, 9, 10].
A secondary form of malnutrition has increasingly been recognised in our aging society
and recently occupied politics [11]. Many elderly have difficulties with food supply due
to age-related handicaps, illness and loneliness thus suffering malnutrition [12]. Besides,
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care institutions struggle with exorbitant high numbers of malnutrition among residents
[13, 14]. Although the majority of malnourished people live at home, malnutrition is
especially precarious in acute disease situations, i.e. when hospitalised [15]. Then, the
disease itself and its treatment influence food intake [16]. Additionally, hospitalised pa-
tients put themselves in the care of physicians and nursing staff. It is reasonable to
suppose that one of the most basic needs - eating - is fulfilled. However, the situa-
tion is different, attributing nutrition and food intake a minor role in comparison to
diagnostic and treatment options during hospital routine [17]. The necessary basis for
convalescence, health and last but not least life is then missing [18].
In this thesis the current state of knowledge on secondary, disease-related malnutrition
is outlined. The development of a nutritional strategy that can be easily implemented
in the clinical setting was of major interest. As the main practical part, this nutritional
strategy was applied and evaluated in a randomised controlled intervention trial which
was performed at Kantonsspital Liestal/Switzerland from January to November 2007.
Great importance was attached to the planning of the study and the homogenous perfor-
mance of interventions as (mal)nutrition studies often lack statistical quality [19]. Once
the first patient was included in the study, busy and demanding eleven months of malnu-
trition screening and treatment started. Patient recruitment, nutritional interventions
and data collection - everything went incredible well. Six months of follow-up went along
with the main intervention study until june 2008 and data analysis started. The results
of this analysis finally objectively verify the subjective personal experiences during the
study time. They show the high potential of an adequate food intake during acute dis-
eases. Patients do eat sufficiently if food is adequately supplied and thus preserve body
weight and a better physical function. Additionally, the higher intake of energy and
protein lead to fewer complications, less antibiotics to treat hospital-acquired infections
and fewer readmissions. A person additional to the ward staff and educated in nutrition
may hence be beneficial for hospital patient care.
In summary, speaking about undernourished people in the developed world still means
speaking about a minority. However, the circumstances leading to malnutrition and the
impact for the individual and society are important. Malnutrition is about to reach the
same high health care costs which are attributed to adiposity/obesity. But in contrast,
malnutrition strategies are rarely implemented [20, 21]. Although nutritional studies
are difficult to perform, nutritionists are encouraged to perform more demanding but re-
warding randomised controlled intervention nutrition trials in order to collect convincing
evidence. By this work the author wants to point to the unfavourable hospital routine
regarding nutritional care and hopes to support the process of finding solutions for a
better nutrition in hospitals.
viii
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1 Theoretical background
1.1 Definition and prevalence of disease-related malnutrition
Disease-related malnutrition is not new [22]. However, empiric data describing the nutri-
tional status of hospitalised patients has been only available since the late 20th century.
According to that, between 20 % and 50 % of all patients are malnourished [23, 24, 25, 26].
The first multi-centre cross-sectional study in German hospitals showed that every fourth
adult patient is malnourished at admission or has a risk of becoming malnourished dur-
ing hospital stay [27]. Prevalence rates thereby depend on hospital departments and vary
from 8 % in gynaecologic patients to 56 % in geriatric patients. However, prevalence
varies even within specialities and appears to depend on numerous options of diagnosing
malnutrition (see table 1.1). Besides, an inconsistent definition of malnutrition is applied
even in current guidelines [28, 29, 30].
Table 1.1: In-hospital malnutrition prevalence
Population Screening tool Prevalence (%) Reference (Year)
Multidisciplinary NRS-20021 32.6 Sœrensen et al. (2008) [31]
General medicine PG-SGA2 53.0 Thomas et al. (2007) [32]
General medicine
and surgery
SGA 39.0 Kyle et al. (2006) [33]
General medicine
and surgery
NRS-2002 28.0 Kyle et al. (2006) [33]
Multidisciplinary SGA 27.4 Pirlich et al. (2006) [27]
Oncology SGA 37.6 Pirlich et al. (2006) [27]
Geriatrics SGA 56.2 Pirlich et al. (2006) [27]
Geriatrics NRS-2002 40.3 Bauer et al. (2005) [34]
Geriatrics SGA 45.0 Bauer et al. (2005) [34]
Oncology PG-SGA 52.0 Segura et al. (2005) [35]
General medicine
and surgery
NRS-2002 39.9 Rasmussen et al. (2004) [36]
Multidisciplinary NRS-2002 22.0 Kondrup et al. (2002) [37]
General medicine NRS-2002 24.8 Kondrup et al. (2002) [37]
1 Nutritional Risk Screening 2002
2 Patient-generated Subjective Global Assessment
1
1 Theoretical background
Only recently an aetiology-based definition of disease-related malnutrition has been
published [38]. Three conditions which combine various degrees of under- or overnu-
trition and inflammation (acute or chronic) are denominated. Hence, malnutrition is
divided into ”starvation-related malnutrition” (no inflammation but starvation like in
anorexia nervosa); ”chronic disease-related malnutrition” (mild or moderate chronic in-
flammation like in cancer) and ”acute disease/injury-related malnutrition” (severe in-
flammation like in burns or trauma). In the latter two, food intake may or may not be
comprised but nutrient requirement is impaired. Additionally, as defined by The Euro-
pean Society for Clinical Nutrition and Metabolism (ESPEN), a ”severe nutrition risk”
can lead to the manifested status and determines outcome especially if inflammation
and a reduced food intake are concurrent disorders [30].
In this work ”malnutrition” is used shortened for the above mentioned term ”chronic
disease-related malnutrition”. As the main focus is placed on macronutrient intake,
malnutrition in this context includes the hitherto favoured term ”protein-energy malnu-
trition (PEM)” as well. However, this term is imprecise since it is often accompanied
by micronutrient deficiencies, does not take the inflammatory component of disease into
account and so far has been rather used to described undernutrition. A nutritional risk
leading to disease-related malnutrition as mentioned above is referred to as such in the
text.
1.2 The underlying causes of disease-related malnutrition
The pathogenesis of malnutrition is multifactorial and underlying causes are often inter-
woven. Apparently, a persistent imbalance between (a decreased) nutrient intake and
(increased) nutrient requirements causes a decline in nutritional status.
1.2.1 Conditions with insufficient nutrient intake
Disease in general is often associated with an impaired nutrient intake [12, 39, 40]. In
particular cancer patients suffer from anorexia or considerable reduction of appetite
[41, 42, 43]. Early satiety typically accompanies tumors of the upper gastrointestinal
tract [44] and advanced stage liver disease (due to hepatomegaly and ascites [45, 46]).
Neurological damage (e.g. stroke) and dysphagia because of mechanical barriers (e.g.
oesophageal tumours) often require artificial nutrition in order to fully cover nutrient
requirements [47, 48]. Taste and odour abnormalities occur during and after tumour
therapy, i.e. chemotherapy, radiation or surgery [49, 50, 51]. Congestive heart failure
and pulmonary diseases are often accompanied by an impaired exercise capacity. Hence,
dyspnoe and physical exhaustion lead to unfinished meals [52, 39, 53]. Especially in geri-
atric patients functional limitations (e.g. uncomfortable or missing dentures and reduced
saliva) contribute to malnutrition [54, 55, 56]. Besides, the elderly may need assistance
to overcome handicaps with cutlery [57, 58]. Both depression, severe dementia and pain
reduce food intake considerably [59, 60]. Vice versa, anorexia can also lead to depression
[61]. In contrast, antidepressants and analgesia, especially opiods, also cause nausea and
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emesis supporting the shortage of nutrients [62, 63, 64]. An unfamiliar environment,
anxiety and loneliness reduce food intake [12, 53, 65]. In contrast, having lunch in com-
pany and an appealing dish with a range of food that can be chosen individually may
increase food intake [66, 67, 68].
1.2.2 Insufficient nutrient intake during hospitalisation
Especially during hospitalisation various factors induce a decline in nutritional status
[37, 69, 70]. In risk patients a rising energy deficit and an ongoing weight loss is reported
during hospitalisation [71, 72]. Polypharmacy and disease treatment may lead to iatro-
genic malnutrition [27, 73]. An insufficient malnutrition treatment algorithm resulting
from a lack of responsibility [74, 75], unawareness among nursing staff [37, 76, 77] and
simply the shortage of nursing staff [17, 58] results in delayed or inadequate nutritional
support. Economic pressures lead to a maximum utilisation of expensive high-tech med-
ical devices and hence crowded waiting lists, long waiting times and meal absences. Ad-
ditionally, nil-by-mouth periods owing to the preparation for an investigation/treatment
(e.g. surgery, colonoscopy) accumulate during a patient’s journey especially if the patient
is treated frequently [78].
1.2.3 Conditions with increased nutrient demands
Higher nutrient intakes may be demanded if digestion and absorption are impaired. In
acute inflammatory bowel diseases, radiation induced enteritis and after intestine surgery
the absorption capacity may be reduced and higher losses must therefore be compensated
[79, 80]. Higher energy needs due to increased energy expenditures have been described
with advanced renal insufficiency or Human Immunodeficiency Virus (HIV) [81, 82].
Moreover, there are patients with normal or even decreased energy expenditures requir-
ing an individually targeted nutrition. For example in elderly patients with pressure
ulcers resting energy expenditure (REE) was not higher than in patients without pres-
sure ulcers [83]. In contrast, REE in patients with quadriplegia increased significantly
in case of pressure sores [84]. Wide variations in total energy expenditure (TEE) were
described in a study with underweight home-living chronic obstructive pulmonary dis-
ease (COPD) patients [85]. Cancer patients show an ambivalent REE alteration which
is possibly related to the tumor stage and to the duration of the disease [86, 87]. While
one third may have increased REE, another third has decreased or physiological REE
[88, 89]. In liver cirrhosis, estimating REE is not at all successful and measurement by
indirect calorimetry should be preferred [90]. Additionally, diet induced thermogenesis
varies between 0.8 to 22 % [91]. A reduced food intake might thus further influence
TEE. Critically ill patients might have increased requirements because of accelerated
depletion during a hypermetabolic and inflammatory response (e.g. in trauma, burns
or acute severe pancreatitis) [92, 93]. However, the concept of hypermetabolism shall
be dealt with care as overnutrition can worsen the outcome, especially during the initial
phase of critical illness [94, 95, 96].
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1.2.4 Molecular basis for the causes of disease-related malnutrition
Inflammation and disease-triggered catabolic conditions make the nutritional status
worse and limit the success of nutritional support at the same time [88, 97]. Espe-
cially skeletal muscle is rapidly lost during the acute host response accompanying the
increased resting energy expenditure and the accelerated protein turn over [98]. Indi-
cators of an impaired immune function dominate in malnourished patients. Thereby,
the inflammatory response is extended and the synthesis of its components is reduced
[99, 100]. The molecular basis for changes of the nutrient intake and the requirements
during this metabolic response are only rudimentarily explored. A different neuroen-
docrine and humoral response of the sick organism promotes catabolic processes [101].
Especially determining in the sick metabolism can the increased action of inflamma-
tory cytokines (TNF-α, interleukins 1 β, 6 and 8), eicosanoids, reactive oxygen species
and catabolic enzymes (caspases, ubiquitin-proteasomes) be [102, 103]. Additionally, the
imbalance of peripheral orexigenic (e.g. ghrelin, neuropetptid Y) and anorexigenic medi-
ators (e.g. leptin, CKK) leads to insufficient food intake [104, 105]. For example, elderly
people have a decreased ability to adapt their energy expenditure to a negative energy
balance [106]. Especially the metabolism of cancer patients is further altered by factors
produced by the tumor, e.g the Proteolysis-inducing factor (PIF) or the Lipid-mobilising
factor (LMF) [107]. How these molecular changes influence the clinical picture and the
pathogenesis of malnutrition in humans is a question of further research.
1.3 Clinical and financial implications of disease-related
malnutrition
In the following section the focus is on the consequences of malnutrition on clinical
parameters, for disease treatment and the economical impact on society. Meanwhile,
there is ample evidence that an insufficient nutritional status limits a positive clinical as
well as economical outcome. For example malnourished patients lose body weight more
often and to a larger extent than their well-nourished counterparts [72]. A decreased
appetite has been found to predict body weight loss [108]. An altered body composi-
tion, for example the depletion of fat-free mass, reduces functionality due to a decrease
of both functional and supportive muscle tissue [109, 110]. Restrictions in activities
of daily living (ADL), hand grip strength but also lung capacity have been reported
for malnourished geriatric, stroke or COPD patients [111, 112, 113]. In comparison to
well-nourished patients, the malnourished generally show a worse adherence to thera-
pies. Cancer patients interrupt a chemo- or radiotherapy more often and struggle with
more side effects in case of a nutritional risk [114]. In malnourished surgical patients
wound healing is impaired [115]. Also, recovering time in patients with femur fracture
is prolonged when several nutritional deficiencies are present [116]. Liver transplanted
patients are more often and longer hospitalised in intensive care units (ICU) when mal-
nourished according to Subjective Global Assessment (SGA) [117, 118]. Malnutrition
significantly influences the ability to resist against infectious complications [119]. Mal-
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nutrition defined by the Nutritional Risk Index, SGA or anthropometric parameters was
associated with a higher occurrence of in-hospital acquired complications in general in-
ternal and surgery patients [120, 121, 122]. Moreover, the complication incidence was
higher in geriatric patients and patients after liver transplantation in case of malnu-
trition determined by the Mini Nutritional Assessment (MNA) or by a combination of
anthropometric parameters [123, 109]. In contrast, perioperativ nutritional support can
prevented complications in malign surgery patients [124].
Measurements of quality of life by general questionnaires, e.g. the Short-Form quality
of life questionnaire (SF-36), or specific questionnaires, e.g. the EORTC-questionnaire
from the European Organisation for Research and Treatment of Cancer, revealed a
decrease in both the physical and mental quality of life (QoL) when malnourished [125,
126, 127]. Malnutrition identified by SGA was related to poorer subjective QoL in a
haemodialysis population [128]. The same applied to elderly patients of a nursing home
with a low Body Mass Index (BMI) [129].
Numerous studies report that malnourished patients stay longer in hospitals depending
on the extent of malnutrition [26, 27, 130]. Surgical and internal patients suffering from
weight loss during hospitalisation were found to be readmitted more often [131, 132, 29].
Also malnourished outpatients as indicated by BMI were more often hospitalised [133].
Because of these adverse effects, malnourished survivors increase average treatment costs
approximately threefold [121, 20]. In contrast, nutritional support was found to be cost-
effective [134, 135]. According to a Dutch investigation an investment of 76 e per day
(i.e. about one fifth of the daily costs) was sufficient to decrease hospitalisation by one
day [136]. Malnourished patients have increased mortality compared to well-nourished
patients in both the ambulant as well as the hospital setting [18, 133]. Cardiac patients’
survival rate was lower when being cachectic [137]. In severely ill patients ICU mortality
was higher in case of malnutrition [138, 139]. A recent Europe-wide study reported
that among 5,000 patients 12 % of malnutrition risk-patients (i.e. NRS-2002≥3) died in
contrast to only 1 % of non-risk patients [31]. These numbers were similar in a Brazilian
study that applied the SGA [121].
1.4 Options to diagnose disease-related malnutrition
In order to address the impact of malnutrition described in the previous section, there
is need for a clear description and diagnosis. Several plasma parameters like serum
albumin or lymphocyte count were discussed to describe the nutritional status [140, 141].
However, those parameters are influenced by the acute disease overlying the effect an
impaired nutritional status would have [142]. In fact, serum albumin was found to be
a strong predictor of morbidity and general mortality in hospitalised patients but not a
nutritional marker [143, 144, 145].
A number of anthropometric parameters like body weight, BMI or the Mid Upper
Arm Circumference (MUAC) have been found to be unreliable to define malnutrition
[27, 29]. However, an (unintended) change in body weight, i.e. body weight loss, has
prognostic value and thus is considered in most malnutrition screening tools [37]. A
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body weight loss of 6 % in six months has been associated with a worse survival rate
in patients with heart insufficiency [146]. Similarly, an altered body composition has
been shown to predict malnutrition. In elderly, cancer and surgical patients the phase
angle of Bioelectric Impedance Analysis (BIA) measurements and the amount of fat-
free mass (FFM) is associated with the nutritional status [147, 148, 149]. Moreover, the
phase angle predicts mortality [150, 151, 152]. Also, functionality measured by hand grip
strength has prognostic relevance [153]. The latter methods are, however, not routinely
applied at present and still reserved to study settings even though hand grip strength,
for example, can be measured easily [154].
A more practicable option to detect malnutrition is a routine screening followed by
a detailed nutritional assessment in risk patients. Meanwhile, various screening tools
are available, but only a few are accepted for the clinical setting, e.g. Nutritional Risk
Screening 2002 (NRS-2002 [155]), Subjective Gloval Assessment (SGA [156]) or Mini
Nutritional Assessment (MNA [157]). These tools are time-saving because they rely on
easily available parameters like body weight, height, eating habits, clinical signs etc.
The NRS-2002 is recommended for hospitalised patients. It is based on a retrospective
analysis of nutrition intervention studies. In comparison to other screening tools the
NRS-2002 shows good concordance [158, 159, 160]. Specificity reaches 93 % whereas
sensitivity is about 62 %, however, experience is needed to overcome high inter-examiner
variability [155, 33]. In the pre-screening patients are classified according to the presence
of a low BMI, body weight loss, reduced food intake and critical illness. The main
screening follows only in case one pre-screening parameter indicates malnutrition (for
details refer to A.1). Thereby a score is allocated, depending on the degree of nutritional
impairment (body weight loss, reduced BMI and food intake) and the severity of disease
(dimension of metabolic stress). Additionally, age is taken into account as a risk factor
(one point added for patients equal or above 70 years). Hence, malnourished and at-risk
patients are identified as soon as the score totals 3. The tool developers investigated
whether the tool was able to select patients who profit from nutritional support (s.
discussion). This issue will also be addressed in chapters 3 and 4.
1.5 Nutritional support for disease-related malnutrition
As described so far, malnutrition has detrimental effects but can be defined easily. Thus,
treatment is important to overcome the adverse effects. However, the integration of indi-
vidual nutritional care in the daily hospital routine is a challenging task [161, 162, 163].
A second challenge is the missing evaluation of nutritional support and the individual
food intake [164, 165, 166]. It was shown in surgical patients that recent food intake is
more important for wound healing than nutritional status defined by recent weight loss
[167]. Even so, several investigations show that large amounts of food are wasted. At the
same time, patients’ nutrient intake is insufficient during hospitalisation [168, 169, 170].
Nevertheless, food intake can be increased as the following sections show.
6
1.5 Nutritional support for disease-related malnutrition
1.5.1 Improving food intake by factors related to nutrition and food
Dietary counselling and timing of nutritional support
The nutritional intake may be improved by dietary advice provided by dieticians or
nutritionists. Evidence, however, is insufficient or of poor quality as information about
the counsellor and content of the advice is mostly missing [171]. Dietary advice is
often compared to supplement intake being inferior or equally efficient in increasing the
energy intake [172, 171, 173]. However, in cancer outpatients dietary advice given during
radiotherapy was the only sustainable option to increase the energy and protein intake
until three months after radiotherapy [114, 174]. Even survival rate and long-term QoL
were improved by the dietary counselling in contrast to supplement or ad libitum intake
[175]. Likewise, both dietary advice and supplement intake led to higher energy and
protein intakes during hospitalisation, whereas only the advice had a sustained effect
two months after discharge [176].
It is especially important to avoid a delay in nutritional support since the highest
impact is expected at the beginning of hospitalisation. This is, however, not the current
practice because a definition of patients who should receive nutritional support is often
missing [177, 178]. One study showed that during hospitalisation malnourished patients
lose more body weight, whereas nutritional support can reverse the body weight loss
[72]. A meta-analysis of early versus delayed nutritional support in ICU revealed a
benefit regarding infectious complications when patients received early nutrition [179].
Additionally, delayed nutritional support led to an irreversible cumulative energy deficit
which was associated with death [180], whereas early nutritional support prevented a
deficit and favoured survival in ICU patients [71].
In-between meals and food fortification
Natural energy-dense ingredients like cream, cheese or margarine increased the sponta-
neous energy intake in nursing home residents [181]. In comparison to a pre-test evalua-
tion, a 36 % increase in energy intake (i.e. 504 kcal/d) was observed. A reduced portion
size and meal fortifications with butter, cream, cheese and glucose powder resulted in a
286 kcal/day increase in energy intake in geriatric patients. The protein intake, in con-
trast, was unchanged [182]. Meals fortified with double cream and skimmed milk powder
and supplementary in-between snacks such as cake or cheese sandwiches resulted in an
increased energy intake of 255 kcal/day. In contrast, the protein intake was again un-
changed [183]. Although natural ingredients are cheap options to raise the energy intake,
the lack of additional protein and micronutrients may be important as the main increase
was achieved by a higher intake of fat in the cited studies.
Oral nutritional supplements
Energy-dense multinutrient supplements (oral nutritional supplements, ONS) may be
offered to patients who prefer drinking their calories [182, 184, 185]. According to a
recent Cochrane review, they increase the energy intake by about 400 (175 to 1350) kcal
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daily when completely finished [186]. However, supplements can reduce the spontaneous
intake of normal food thus masking a lower food intake in the elderly [108, 187]. A large
body of evidence shows the remarkable influence on outcome [188, 186]. Muscle functions
and the quality of life have been improved in patients with non-neoplastic gastrointestinal
diseases. Moreover, the rehospitalisation frequency was lower in comparison to patients
treated with dietary advice only [173]. An additional mean intake of 407 kcal via ONS
for two months resulted in the conservation of the body weight in elderly patients [189].
Even mortality was reduced in undernourished patients if the ONS were taken sufficiently
[188]. Meanwhile, ONS are well manageable but the compliance is low outside study
settings [190, 191, 192, 193]. Reasons comprise draw-backs in palatability and sensory
aspects leading to taste fatigue [49, 194]. However, taking supplements like medication
(i.e. several times a day a small volume) may be an option to raise acceptance and
energy intake [195, 196]. An increase in energy intake may thus depend on supplement
acceptance [197], which in turn shows that ONS may not be suitable for all patients.
Individualisation, decentralisation and staff education
A patient-driven individual multifactor approach may be the best option to increase
food intake. A dietician/dietetic assistant and a nurse provided nutritional support and
achieved increased energy and protein intakes in two studies [198, 199]. However, training
the standard ward staff in nutrition did not increase the food intake [200]. Furthermore,
nutritional support provided by assistants additional to the ward staff and trained in
nutrition did not increase food intake in mal- and well-nourished geriatric patients [201].
In contrast, a questionnaire-based Scandinavian study found that if the ward staff is
aware of malnutrition and several nutrition strategies were implemented, then nutrition
care was improved [202].
The patients’ satisfaction with the catering service has been shown to be important
for food intake [69]. A room service-like catering increased patient satisfaction with the
food service and led to higher intakes of energy and protein in children having cancer
[203]. However, dining with a family member did not [204]. A decentralised bulky food
production system increased food intake and in contrast decreased wastage in comparison
to a plated system [205]. A Danish study found an improved food intake and reduced
amounts of wastage with a buffet-like catering system for dinner. Patients thereby chose
their food individually and more flexibly on the ward. Increased intakes (from 128 KJ to
560 KJ per patient) were reported for those patients with insufficient intakes. Patients
eating adequately with the old system did not increase their intakes [68]. In contrast,
in-between meals offered by a manned trolley did not increase the energy nor the protein
intake in a second Danish study [206].
Restrictive diets and starvation
The plausibility of specific diets is currently more and more questioned because diets
may increase the malnutrition risk especially in elderly patients [207, 208]. For surgery
patients it has been shown that the postoperative feeding can progress quickly and
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specific modified diets do not show advantages [209, 210, 211]. In contrast, surgery
may even be delayed in order to improve the nutritional status in severely malnourished
patients [212]. The need for a texture-modified diet may closely be re-evaluated since
food intake can be less than with a normal diet [213]. The diabetic diet and diabetic
food products are meanwhile considered obsolete in Germany [214]. Moreover, the effect
of a weight-reducing diet in hospitals can be questioned as the nutrient intake is more
likely decreased to an insufficient intake [215, 216]. Attention should be paid to frequent
and prolonged nil-by-mouth times [78]. In particular, a carbohydrate drink can safely be
applied until two hours before an operation or investigation with risk of aspiration due
to anaesthesia. The stomach has been shown to be empty in sufficient time and insulin
resistance was shortened after surgery thus reducing the stress response and even the
length of hospital stay [217, 218].
Medication to promote appetite
Appetite stimulants may be applied to counteract anorexia. In animal models investi-
gating muscle degradation promising results have been obtained, for example, in tumor
bearing rats [219]. Especially progestins, corticosteroids or recently cannabinoids were
thought to promote the appetite but their use is controversial. So far, there is only
little evidence to draw a conclusion from animal models to human beings. Although
the sensation of appetite was found to be better under a cannabinoid in AIDS patients,
there was no significant effect on the body weight or other outcome parameters [220].
A review of megestrol acetate showed neither influence on the quality of life nor the
survival rate in cancer patients [221]. Because of unsatisfactory results and side effects
these drugs are thus limited to research and palliative care [222, 223].
1.5.2 Improving food intake by factors related to hospitalisation
Optimal treatment of disease and side effects
Drawbacks in the treatment of disease or even treatment failures may also influence food
intake directly or indirectly. It was shown in a prospective study that patients’ food in-
take is significantly decreased during treatment episodes, whereas between treatments
the intake returned back to normal [73]. Also, a low food intake correlated with symp-
toms related to treatment side effects in patients with acute leukaemia receiving poly-
chemotherapy [224]. Cancer patients suffering pain were more often malnourished than
those without pain [60]. Minimal invasive procedures and sufficient pain relief reduce
the stress response due to surgery and therefore are beneficial for the nutritional status
and even morbidity and mortality [225, 226]. Furthermore, an adequate pain treatment
may increase the energy and protein intake shortly after surgery [227]. The reduction of
both postoperative ileus and opiod side effects provide a beneficial environment for early
oral nutrition [226, 228]. First of all, adequate disease treatment is important to avoid
the aggravation of disease thus requiring artificial nutrition or rehospitalisation [229].
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Human resources and protected mealtimes
The hospital environment has profound influence on the food intake not only because of
being unfamiliar to the patients but a daily routine which is unfavourable for eating [57].
Patients often experience extended nil-by-mouth times, although it was shown that two
hours of starvation are sufficient before anaesthesia [78]. A couple of studies investigated
whether protected mealtimes, i.e. periods during the day reserved for food intake or
providing help with eating, influence food intake [163, 230, 231]. Indeed, in the United
Kingdom (UK) a campaign was launched to introduce protected mealtimes in hospitals
all over the country [232]. Currently, the results are still inconsistent mainly due to
challenges related to the implementation of protected mealtimes [233, 234]. However, a
successful implementation of protected mealtimes together with further interventions like
an improved catering and the screening for malnutrition resulted in decreased prevalence
rates of malnutrition [235].
A recent German-wide study among 10,000 nursing staff revealed that basic care
procedures cannot be provided due to staff reduction and work overload while patient
numbers increase. However, providing nutritional assistance during mealtime requires
additional time [236]. About one in three nurses state that patients are not assisted
adequately during mealtime. Among the most exhausted nurses every second states that
nutritional assistance is often not provided adequately [17]. Furthermore, the interaction
between patient and nurse during the mealtime has been shown to be beneficial for the
energy and protein intake [237]. In addition, patient-nurse ratios are related to general
morbidity such as catheter infections during parenteral nutrition [238].
1.6 Shortcomings of nutrition studies
As shown above, numerous descriptive studies elucidate the implications of malnutri-
tion on several outcome measurements [168]. However, they do not present the causal
link between malnutrition, their causes and their consequences. In fact, malnutrition
affects severely ill or terminal patients more often than healthy people or those with
mild diseases. Vice versa, a severe disease can lead to malnutrition. Especially, outcome
parameters like mortality and length of hospitality are obviously influenced by several
factors apart from malnutrition (e.g. hygiene, severity of disease, age [239]). Whether
the relation of malnutrition and a worse outcome reported in descriptive studies is causal
and hence reversible can thus only be determined by well-designed intervention studies.
Unfortunately, results of hard outcome intervention trials have been rather heterogenic
up till now. The transferability outside a study setting is questioned especially con-
cerning oral supplements. For ethical reasons there is no study of nutritional support
vs. no support in risk patients. Often, control patients receive dietary advice being
either superior or inferior to the test intervention, i.e. ONS intake. Thus, patients in
Portugal [114] seem to be better advised than patients in Berlin [173]. Therefore, stud-
ies are hardly comparable. For practical reasons historic control groups are compared
to present intervention groups in case a nutritional protocol was newly introduced to
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a whole ward [240, 215]. A considerable number of biases may then influence the re-
sults. Finally, large study populations are crucial to achieve sufficient statistical power
for hard outcome studies. In multi-centre studies, however, interventions and settings
are less homogenous, thus complicating the disclosure of nutritional effects.
So far, nutritional support including normal food has not been considered extensively.
In contrast, the European Council resolution ResAP 2003(3) on food supply in hospitals
stated that first of all normal food shall be chosen for the prevention and the treatment
of malnutrition [241]. If patients do not meet their requirements, fortifications and fi-
nally ONS can be used. The latter shall be an addition and no replacement. Until the
preparation of this script, only three studies had investigated the effect of a multifactor
intervention that conforms with the classic concept of ”nutritional therapy” in hospi-
talised patients. They present opposing results most likely due to statistical deficits, i.e.
heterogeneous study populations, bias and insufficient nutritional interventions. Thus,
there is need for more randomised controlled intervention phase III trials [19].
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2 Preliminary work and study preparation
2.1 Results of the pilot study
Two minor investigations were performed at Kantonsspital Liestal hospital previously
to the intervention study. First, anthropometric parameters describing the nutritional
status (body weight, body height, BMI, body weight change) were investigated in 107
patients’ charts in October 2005. At admission, in 60 % of the charts body weight and
height was recorded but in 13 % only, the BMI was calculated. Body weight change,
i.e. a second measurement of body weight during hospitalisation, was registered in one
fourth of patients. These results indicate that patients with a risk of malnutrition are
not routinely detected.
From December 2005 to January 2006 an investigation on food supply was performed
[169]. The amount of food that was eaten by the patient was visually estimated in 1178
menus. Quantities of 0 %, 25 %, 50 %, 75 % or 100 % in comparison to the initial amount
were defined with the help of the 4-quadrant model. Less than half of all portions (46 (5)
%) were finished completely. A waste rate of 24 (1) % was calculated. Up to one third of
all meals were ordered as ”semi portion” and not finished more often than a full portion.
Although the offered menus showed sufficient nutrient content, the energy intake was
remarkably reduced. Less than 1500 kcal/d were consumed by the majority of patients
(the mean energy intake was 1340 (357) kcal/d). The nutrient intake was concluded to
be insufficient and considered a risk factor in the management of malnutrition.
2.2 Preparations for the randomised controlled intervention
trial
2.2.1 Record sheets applied in the trail
Data record sheets were developed in order to collect all study data efficiently. For pa-
tient recruitment a continuously numbered recruiting list was compiled. For admission
and discharge data the standard NRS-2002 sheet was modified. Main outcome param-
eters were added, i.e. patient code, body weight, height, diagnoses, medication, and
date of admission. Check boxes for further analyses (blood) and the follow-up data
were added in order to improve integrity. A detailed anamneses sheet was applied with
each intervention patient. Interventions were recorded on an individual record sheet for
each patient. All sheets were tested before the start of the study in order to identify
practicability and are compiled in the appendices A.2.
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2.2.2 The intervention strategy of the trial
A concept for the nutritional support was developed that was based on the pilot studies
[169] and the literature research (see Introduction). Although there is little evidence,
there is consensus that nutritional support should conform to a stage model preferring
the more natural and simple way of food intake to the more artificial/invasive way [242].
Studies show fewer complications, an easier handling and lower costs for natural food
compared with artificial nutrition [243, 244, 245]. However, details of such a strategy
have to be defined individually according to the patient’s need. Since natural food is the
preferred nutrient source in this study, the two first stages of nutritional support are the
most important, i.e. abolish eating barriers and individualise food ordering and intake.
Additionally, oral nutritional supplements, food fortification and in-between snacks are
provided. Aspects related to individualisation, dietary counselling, decentralisation,
timing of support, restrictions and side effect treatment are also realised (for details
refer to 1.5.1 and 4.2. Basically, interventions conform to the ESPEN guidelines for
enteral nutrition (see www.espen.org and [177]).
Energy requirements as an intervention target
The patients’ daily individual needs on energy and protein determine the extent of
nutritional support. In order to define the intervention target, the total daily energy
expenditure (TEE) can be estimated. Thereby the resting energy expenditure (REE),
accounting for about 60 %, provides the basis of TEE [246]. The latest investigations on
REE were published by Mueller et al. [247]. Retrospectively, data of indirect calorimetry
measurements in seven research centres in Germany was analysed and cross-validated.
REE-equations according to different BMI groups were developed, taking the high preva-
lence of adipose and obese (otherwise healthy) people into account. A comparison of
equations revealed that the normal body weight equation may best fit to our study
population (see equation 2.1) while others have shortcomings (e.g. low and high BMI
equation by Mu¨ller et al., WHO, Harris-Benedikt [248, 249, 250, 251]).
REE(kcal) = (0.02219× bodyweight+ 0.884× sex− 0.01191× age
+ 0.02118× height+ 1.233)× 10004.18 (2.1)
The majority of patients - although being malnourished - were expected to belong to
the ”normal BMI” group (18.5-25 m/kg2). In order to calculate REE in obese people,
an adapted body weight was used, which can be adjusted by the same stress factors
used for underweight and normal weight people. To calculate the adapted body weight,
half of the difference between ideal and actual body weight was added to the ideal body
weight [252].
About 30 % of the TEE depend on the physical activity of a person. Thus a factor
defining the physical activity level (PAL) has to be added (see table 2.1). As patients
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Table 2.1: Physical activity level and stress factors
Condition/disease PAL or SF Condition/disease PAL or SF
Sleeping 1.0 [254] Limited mobile 1.2 [252, 254]
Bed-bound 1.1 [255] Mobile 1.3 [252]
BMI<18 1.2 [252] Small surgery 1.2 [252]
Sepsis 1.3-1.4 [252] Short-term fasting 0.9-1.0 [252]
Intestinal Bowel Disease 1.0-1.1 [252] Decubitus 1.0-1.3 [256, 83]
Haematological disease 1.3 [252] Long bone fracture 1.3
Myocardial infarct 1.1 Pancreatitis 1.1-1.2 [252]
Cancer 1.1-1.3 [252, 89] Liver disease 1.0-1.2 [252, 257]
High temperature 1.1/°C [252, 258] Convalescence after
surgery
1.1-1.3 [259]
Severe infection 1.3 [252]
mainly are bedbound and the energy expenditure through exercise (i.e. PAL) is kept to
a minimum, the total energy expenditure is mostly less than under healthy conditions.
However, during disease metabolic stress may increase the REE. Hence, a stress factor
(SF) is needed to adjust the REE [253] (see equation 2.2). However, these SF are not
available for the majority of diseases and vary even within one diagnosis group. Barak et
al. published a large number of stress factors for different diagnoses [252]. These stress
factors were compared to other publications and finally provided the basis for our study
intervention (see table 2.1). The majority of stress factors range between 1.1 and 1.3 and
thus form a frame with only little inter-disease variability and tolerable error margin.
However, short-term evaluations of the intervention are still necessary in order to ratify
the right treatment strategy. As the aim of the study was to compensate a deficient
nutrient intake ”as well as possible” in patients with a highly variable metabolism, exact
individual requirements were not crucial.
TEE(kcal) = REE × PAL× SF (2.2)
Protein requirements as an intervention target
As with energy, expert opinions about the daily protein requirement differ widely [260,
261]. Numerous conditions are known where a low protein intake has positive effects
[262, 263]; however, recommendations on protein intake have been adjusted upwards
year after year [264, 265]. Evidence on protein requirements is most of all based on
nitrogen balance studies showing a not negligible number of shortcomings and small
population groups [266, 261]. On the other hand, the variations in metabolic stress
(see above) within a disease group also influence the energy balance and thus nitrogen
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balance and protein requirements [267]. Current guidelines recommend elevated protein
requirements during mild to moderate disease [268, 269, 270]. The minimum amount of
1g protein per kilogram body weight was assumed to be necessary to achieve nitrogen
balance in geriatric patients, during mild pancreatitis, in cancer patients and acute
renal failure [271, 59, 272, 265]. Furthermore, proteins contribute to about 15 energy
per cent of total energy intake in a natural mixed diet. Thus, about 1g protein per kg
body weight is consumed with a diet containing 15 energy percent provided by protein
(variations depend on the body weight). Since the intervention was planned to mainly
consist of natural food, a protein intake of 1 g/kg body weight was thus constituted the
intervention target. More elevated protein targets would be hard to achieve with mainly
normal food.
16
3 Hypothesis and study objectives
3.1 Hypothesis
The intake of food is reduced during hospitalisation according to the literature and our
pre-investigations. Besides, a malnourished condition is related to a worse outcome.
Especially patients with a malnutrition risk may profit from nutritional support but
unfortunately are not detected at hospital admission. We assume that by increasing
food intake in patients who are malnourished or at risk of malnutrition the outcome can
be improved. However, the statistical approach must be well thought-out. Otherwise,
the impact of nutrition might be concealed. Therefore, only patients with a high chance
of profiting from nutritional support must be included (i.e. risk patients screened by
NRS-2002, no terminal patients). The study setting, notably the interventions and their
evaluation, must be homogenous. Interventions should be monitored and if not successful
(e.g. food was not consumed), compensation must be organised directly. A successful
intervention, i.e. an increased food intake, limits our hypothesis. If no improvement
in food intake is achievable, patients with a risk of malnutrition are simply sicker than
those without, i.e. the outcome criteria are exclusively influenced by the disease and not
essentially by nutrition.
3.2 Study objectives
The aim of the present study was to develop and evaluate a routinely manageable concept
for an improved nutritional care of malnourished in-hospital patients defined by NRS-
2002.
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4 Patients and methods
4.1 Randomisation and study inclusion
The study was conducted as a randomised controlled intervention trial from January
2007 to November 2007 (intervention period; follow up until June 2008) until a sufficient
number of patients had been recruited (see statistics). The study protocol was ap-
proved by the ethic committee of the University of Basel/Switzerland. All patients were
informed about study objectives and procedures and signed written informed consent
before the inclusion.
During the study period, all adult patients consecutively admitted to the general medi-
cal ward at ”Kantonsspital Liestal” hospital were screened for their nutritional risk using
the NRS-2002 questionnaire. Exclusion criteria were: no informed consent, terminal con-
dition, expected stay less than 5 days (judged by physician), previous participation in
this study, being on starvation or parenteral nutrition, and/or being on dialysis. Pa-
tients with a nutritional risk (i.e. a NRS-2002≥3) were recruited and randomised to the
intervention group (IG) or the control group (CG) according to a computer-generated
randomisation list. Thus, patients received either individualised nutritional support for
5 to maximum 28 days (IG) or standard hospital care (CG). Patients with an initial
score below 3 were re-evaluated weekly during the study’s intervention period and asked
for participation in case a nutritional risk developed during hospitalisation.
4.1.1 Study endpoints and data collection
The primary endpoints of the study were the average daily energy and protein intake.
As secondary parameters the changes in body weight during hospitalisation, number
of complications, number of antibiotic therapies due to infectious complications, length
of hospital stay, quality of life Short Form 36 questions (SF-36) questionnarie, hospital
re-admission (six months after discharge), mortality (hospital and six months after dis-
charge), compliance with oral nutrition standard supplement consumption and plasma
concentrations of 25-OH-D3, ascorbic acid and glutathione were evaluated.
All baseline measurements were made within 72 hours after admission. Body weight
was measured in all patients on a chair scale (100 g precision) in light clothes without
shoes in the morning. The body weight of patients with oedema was recorded at admis-
sion, as was the body weight of patients being dehydrated. No corrections for dysbalances
of the water balance were applied. Body height was asked or taken from the personal
identity card. The sensitivity of self-reported height was judged sufficient for our study
purpose [273]. In case body height was not available it was measured using a stadiometer
(1 cm precision) or transposed from knee length measurements (when the patient was
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not able to stand upright [273]). Quality of life was recorded by the SF-36 questionnaire
filled out either by the patients themselves or by an experienced interviewer. Venous
blood samples were taken after an overnight fast by the nurses on duty. Throughout the
study period, the intake of medication and new complications were recorded daily and
confirmed by the physician on duty. Complications were defined as all hospital acquired
unexpected events, i.e. all diagnoses apart from the diagnosis leading to hospitalisation
occurring at least 5 days after admission. These include infectious complications (res-
piratory tract, urinary tract, wound, catheter infection and others) and non-infectious
ones (decubitus, wound dehiscence, abscess, respiratory failure, cardiac arrest, insuffi-
ciency or arrhythmia, diarrhoea (non-infectious), pneumonia, gastroenteritis, liver and
kidney failure, cerebral bleeding, thrombosis and others). Complications were diagnosed
and recorded by the physicians (who were not involved in the study) according to local
hospital guidelines.
Before discharge (i.e. the decision of the responsible physician) all baseline measure-
ments were performed again. The actual length of stay (LOS) based on admission and
discharge dates and the possible LOS (based on admission dates and the physicians es-
timate of when the patient was ready to be discharged) in the general medical ward and
in hospital were calculated.
4.2 Nutritional intervention
Patients of CG received standard nutritional care including the prescription of oral nu-
tritional supplements and nutritional therapy prescribed by the physician independently
of this study and according to the routine ward management.
Patients of IG received individual nutritional care, including a detailed nutritional
assessment, individual food ordering, fortification of meals with maltodextrin, rapeseed
oil, cream and/or protein powder, in-between snacks and oral nutritional supplements.
Nutritional interventions were applied according to the patients’ need and preferences.
Main meals were ordered according to the menu. Simple variations in order to meet
the patient’s taste were ordered directly in the kitchen. Texture modifications were
offered if needed, but avoided whenever possible due to disadvantages (refere to 1.5.1).
In-between meals, mostly easy to swallow and fresh items, i.e. dairy products blended
with fresh fruits, were offered one to two times the day. In-between meals were stored
in the ward’s kitchen fridge until served. Depending on the patient’s compliance, ONS
was offered at room temperature, cooled or frozen as ice. Different tastes were tried
in order to increase compliance. All interventions aimed at meeting the daily energetic
requirement according to the individual total energy expenditure (TEE; calculated from
resting energy expenditure (REE) corrected by an individual factor for physical activity
level (PAL) and disease (stress factor, SF)). Protein intake was set at 1.0 g/kg body
weight. Complications influencing feeding (e.g. nausea) were reported to the ward
physician and treatment was optimised (e.g. medication).
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4.2.1 The evaluation of food intake
Reference menus were weighted to have the detailed size/weight of each food item and the
corresponding energetic and protein contents were calculated (with PRODI® basing on
the German Bundeslebensmittelschlu¨ssel II.3,). Food intake was observed during meal
times. The consumed part of each food item was visually estimated and recorded. In case
less than 75 % of the portion (i.e. served food at one meal with known energy/protein
content) offered had been consumed, energy and protein intake was compensated on a
daily basis by supplying either ONS (Resource (Nestle´ Nutrition)) or in-between meals
in IG. Snacks, drinks and ONS which were additionally consumed were reported by the
ward staff and the author or the patients have been asked for. In case of starvation
before invasive investigations or surgical procedures a lipid-free ONS was used instead
of the standard ONS. Finally, with the help of PRODI® database, each daily kcal and
protein intake was calculated based on the consumed food items. Food which was not
in the database (e.g. fortified drinks or personal snacks) was entered before calculation.
Energy given by the intravenous route, e.g. 5 % glucose solution, was added to the oral
intake. Except of energy and protein intake, all outcome data were blinded in terms of
that physicians and nurses who were responsible for the outcome did not have access to
group allocation.
4.2.2 The evaluation of ONS compliance
The compliance of ONS consumption was analysed for standard ONS only and presented
in two ways. First, compliance of ONS intake in % was calculated by taking the amount
of ONS consumed divided by the amount the patient should have consumed and mul-
tiplied by 100. According to manufacturer information the consumption of ONS can
be improved by f. ex. cooling, blending with other food, portioning etc. The volume
consumed was therefore corrected and transformed into a five-point compliance score
(adapted from Spillmann et al. [274]). On the one hand, corrections involved the ad-
ditional afford (help) that was needed to prepare the ONS since time at the ward was
limited. On the other hand, the patients’ reliability was considered. Taking the ONS too
late (i.e. too close before the next main meal (like a ”pre-meal snack”)) may decrease the
amount of food consumed at main meals [275, 187]. Taking the complete ONS without
any help and high reliability then means five points. Taking it completely but too late
(no reliability) means four points, as means taking all with much help (i.e. more than
bringing the drink, opening it and putting the straw into it). A person who consumed
25 % only and needed a lot help or had no reliability then receives one point.
4.3 Blood sampling and analyses
At admission and before discharge, venous blood was withdrawn into heparinised tubes
and directly centrifuged. The plasma aliquots for 25-OH-D3 and glutathione were frozen
and stored at -80 °C until the analysis. Plasma specimen for ascorbic acid analysis were
deproteinised and stabilised using meta-phosphoric acid-perchloric acid solution and
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stored at -80 °C until analysis. Frozen samples were transported to the central lab in
Bonn. Ascorbic acid detection was carried out by HPLC with UV detection [276]. The
analysis of 25-OH-D3 was achieved by enzymatic immunoassay (ELISA kit from IDS
Frankfurt/Germany) and the detection of glutathione after separation of metabolites by
fluorescence detection [277].
4.4 Follow-up
Information concerning the re-admission and 6-months-mortality was obtained by the
patients hospital computer register or by calling either the patients themselves or their
general practitioners, respectively, six months after discharge.
4.5 Statistical analysis
The level of statistical significance was set at p<0.05. A p-value between 0.05 and 0.1
was considered a statistical trend. Sample size (with a power of 0.9, two-sided, p=0.05)
was calculated based on an increase in energy intake by 15 % (285 kcal; effect size). The
standard deviation of energy intake calculation has been taken from the pilot study (see
preliminary investigations and [169]). Including a 15 % drop out rate, at least 60 patients
were required per study arm. Statistical analyses were performed using SPSS 13.0.
Normal distribution was verified using statistical tests (Shapiro-Wilk and Kolmogorov-
Smirnov test) and graphical methods (box plot, histogram and normal Q-Q plot). The
effect of intervention was tested by repeated measure ANOVA. Statistical differences of
the baseline and outcome data were tested by Chi2 or Fisher’s exact test (binary data)
and by Mann-Whitney- or independent samples t-test (quantitative data). The baseline
SF-36 QoL study data was compared to a normal reference population using one way
ANOVA (Welch statistic). Variance homogeneity was checked using Levene’s test and
post-hoc analysis performed with the Games-Howell test. All results are presented as
mean (standard deviation) unless otherwise indicated.
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5.1 NRS-2002 screening and patient recruitment
In total, 767 patients were consecutively admitted during the study period including
271 who were registered with an NRS-2002≥3. According to the predefined criteria, 137
patients were excluded among those patients at parenteral nutrition (for details refer
to figure 5.1). Patients with psychiatric disorders or severe dementia were listed under
”no I.C.”. Unconscious patients rank among the group ”nil per mouth”. Allowing for
57 patients who were readmitted and excluding terminal patients, the patient-related
malnutrition risk prevalence was 32 % for all admitted medical patients. The subgroup
prevalences are presented in table 5.1.
Table 5.1: Malnutrition risk prevalence rates
Patient group Frequency NRS-20021≥3 (%)
All 232 of 684 34
All medical 231 of 672 35
All medical excl. terminal 206 of 647 32
Non-medical 1 of 12 8
Dialysis 3 of 10 30
Non per os 7 of 7 100
Short hospitalisation 16 of 50 32
No I.C.2 56 of 56 100
Terminal 25 of 25 100
1 Nutritional Risk Screening 2002
2 Informed Consent
Finally, 134 patients were equally randomised to CG and IG, respectively. Due to a
wrong initial diagnosis, one patient in each group had to be excluded because a malnutri-
tion risk according to NRS-2002 was no longer detectable. Thus, the Intention-To-Treat
population (ITT) consisted of 132 patients with each 66 patients in IG and CG, respec-
tively. All but 16 patients were included at admission. Those 16 developed a nutritional
risk during hospitalisation and were included after 7 (7) days. Due to protocol violations
(death or discharge before the minimum intervention period (n=13) and withdrawal of
informed consent (n=1)) further 14 patients were excluded from the Per-Protocol pop-
ulation (PP).
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Randomised patients
n=134
Allocated to intervention group n=67
• Received study therapy as randomized: 
n=67
• Did not receive study therapy as randomized: 
n=0
Allocated to control group n=67
• Received study therapy as randomized: 
n=67
• Did not receive study therapy as randomized: 
n=0
Protocol violations n=8
• Incorrect diagnosis: n=1
• Discharged/died before minimum intervention 
period: n=6
• I.C. withdrawal: n=1
Protocol violations n=8
• Incorrect diagnosis: n=1
• Discharged/died before minimum intervention 
period: n=7
Data analysed (Intention-To-Treat): nITT=66
• Excluded from analysis: n=1
(reason: withdrawal of I.C. 1h after inclusion, 
no intervention, no data collection 
until that time: n=1)
Data analysed (Per Protocol): nPP=59
• Excluded from analysis: n=7
(reason: discharged or died before minimum 
intervention period n=6
incorrect diagnosis n=1)
Data analysed (Intention-To-Treat): nITT=66
• Excluded from analysis: n=1
(reason: died before first data collection, no 
intervention until that time: n=1) 
Data analysed (Per Protocol): nPP=59
• Excluded from analysis: n=7
(reason: discharged or died before minimum 
intervention period: n=6
incorrect diagnosis n=1)
Assessed for eligibility
n=767
Patients at nutritional risk
(NRS≥3) 
n=271
No NRS available
n=6
NRS<3
n=490
Excluded: n∑=137
Not internal: n=2
Terminal patients: n=27
No I.C.: n=61
Short hospitalisation: n=24
Dialysis patients: n=4
Nil per mouth: n=9
Former study participants: n=9
Parenteral nutrition: n=1
Follow-Up: nITT=66
Follow-Up: nPP=59
Follow-Up: nITT=66
Follow-Up: nPP=59
Figure 5.1: Study flow chart
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5.2 Baseline characteristics of the study patients
The baseline demographic and clinical data of patients in IG and CG (n=66 each) are
given in table 5.2. The majority of patients were women (CG: 40/66 vs. IG: 47/66;
p=0.271). Height, body weight, BMI, initial diagnoses, average NRS-2002 subscores,
number of oral drugs, REE, TEE, SF/PAL and QoL did not differ between groups.
Table 5.2: Baseline data
Variable Randomi-
sation
Mean (SD) Median (min-max) Variance Signifi-
cance
Age CG1 75 (11) 76 (43-94) 113 0.091
IG2 70 (16) 73 (21-94) 267
Height CG 165 (10) 165 (147-192) 100 0.633
IG 166 (8) 165 (148-190) 65
Body CG 66.1 (16.2) 65.6 (29.6-99.0) 262.9 0.504
weight IG 68.1 (16.9) 67.4 (39.7-119.0) 286.1
BMI CG 24.1 (4.9) 23.6 (13.2-42.3) 24.0 0.527
IG 24.6 (5.3) 24.3 (14.9-38.4) 27.9
NRS-2002 CG 1.0 (0.3) 1 (0-2) 0.1 0.057
disease score IG 0.9 (0.5) 1 (0-2) 0.2
NRS-2002 CG 1.7 (0.7) 2 (0-3) 0.5 0.233
nutrition score IG 1.8 (0.6) 2 (1-3) 0.4
Number CG 7 (3) 7 (0-12) 7 0.465
oral drugs IG 6 (3) 6 (1-14) 9
REE CG 1352 (207) 1328 (970-1785) 42802 0.845
IG 1359 (188) 1327 (1068-1768) 35442
Sum of SF CG 1.3 (0.1) 1.3 (1.2-1.4) 0.0 0.107
and PAL IG 1.3 (0.1) 1.3 (1.1-1.4) 0.0
TEE CG 1733 (258) 1721 (1272-2321) 66810 0.907
IG 1728 (227) 1712 (1348-2211) 51316
1 Control Group
2 Intervention Group
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A mild stress metabolism (subscore 1) and a moderate nutritional impairment (sub-
score 2) were most often allocated during the NRS-2002 screening. In 62 patients the
nutritional subscore was given because of a reduced food intake. Weight loss led in
26 patients and both of these criteria in 43 patients to the respective subscore. The
nutritional subscore covered the whole range of possible disorders (i.e. subscore 0 to
3) whereas the disease severity subscore 3 (typically describing ICU patients) was not
assigned. Baseline mean estimated REEs were equal among groups (table 5.2). The
factor to ajust REE (i.e. the sum of PAL and the disease derived Stress Factor) was 1.3
(0.1) in both groups. Thus the calculated TEEs were similar between groups (table 5.2)
although a wide range of the TEEs from 1272 to 2321 kcal was observed.
All initial diagnoses according to ICD-10 coding are given in table 5.3. One third
(41/132) of all patients was hospitalised due to main or secondary diagnosis related
to a malign tumour. The majority of patients was hospitalised because of a disease
related to the cardio vascular system (100/132). In addition, 49 out of 132 patients
received diuretics (no group difference) in order to promote weight loss because of cardiac
insufficiency. Polypharmacy was common. In IG 39 of 66 patients and in CG 44 of 66
patients (p=0.471) received more than five oral drugs. Nine patients received nutritional
therapy prescribed by the physician (CG: 4/62 vs. 5/61, p=1.000).
Table 5.3: Diagnoses according to ICD-10 coding3
ICD-10 code Randomisation Frequency
Infectious and parasitic CG1 10
disease IG2 4
Neoplasms, diseases CG 17
of the blood IG 13
Endocrine and metabolic diseases, CG 11
diseases of the digestive system IG 12
Diseases of the nervous system, CG 2
the eye and adnexa IG 5
Diseases of the CG 14
circulatory system IG 15
Others CG 12
IG 17
1 Control Group
2 Intervention Group
3 International Classification of Diseases (10th edition)
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The baseline quality of life scoring is given in table 5.4. No differences appeared
between groups. However, all values were reduced compared to a healthy reference
population (refere to the appendices, section A.4).
Table 5.4: SF-36 baseline datab
Scalea Randomi-
sation
Mean (SD)c Medianc
(min-max)
Variance Signifi-
cance
SF-36 PF CG1 25 (25) 20 (0-85) 606 0.357
IG2 25 (24) 20 (0-95) 582
SF-36 RP CG 4 (9) 0 (0-25) 78 0.525
IG 10 (24) 0 (0-100) 590
SF-36 BP CG 49 (33) 41 (0-100) 1112 0.117
IG 42 (35) 32 (0-100) 1199
SF-36 GH CG 50 (20) 50 (15-95) 414 0.493
IG 51 (19) 52 (10-100) 376
SF-36 VT CG 27 (19) 25 (0-75) 349 0.216
IG 22 (19) 15 (0-90) 368
SF-36 SF CG 69 (31) 75 (0-100) 977 0.117
IG 58 (33) 63 (0-100) 1068
SF-36 RE CG 54 (48) 67 (0-100) 2260 0.642
IG 50 (49) 33 (0-100) 2423
SF-36 MH CG 64 (17) 60 (36-100) 276 0.073
IG 59 (20) 56 (16-100) 410
SF-36 PCS CG 27 (7) 26 (10-42) 48 0.437
IG 28 (8) 28 (10-47) 64
SF-36 MCS CG 48 (11) 48 (25-69) 130 0.081
IG 44 (12) 44 (24-66) 143
a SF-36 abbreviations: PF-Physical Function, GH-General Health, RP-Role Physical,
BP-Bodily Pain, SF-Social function, RE-Role emotional, MH-Mental Health, VT-
Vitality, PCS-Physical Component Summary, MCS-Mental Component Summary
b for all SF-36 sub- and summary scales: n=49 (CG) and n=55 (IG)
c in %
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Baseline plasma levels of ascorbic acid (IG: 34.2 (21.1) vs. CG: 27.2 (20.4) µmol/l)
and glutathione (IG: 4.07 (2.36) vs. CG: 3.76 (1.98) µmol/l) were comparable in both
groups. In contrast, 25-OH-D3 concentrations were higher in IG (51.9 (23.7) nmol/l
vs. CG: 44.8 (25.5) nmol/l; p=0.020, table 5.5). However, the number of patients with
concentrations below the reference for healthy people was equal in both groups (table
5.6). One third of all patients (43/132) showed ascorbic acid values below the reference
level of 17 µmol/l. For 25-OH-D3 (25 nmol/l), only 12% (16/132) and for glutathione
(2.2 µmol/l) one quarter (33/132) showed low levels (no differences between groups). No
seasonal differences in 25-OH-D3 levels were found.
Table 5.5: Micronutrient baseline concentration
Micronutrient Randomi-
sation
Mean (SD) Median (min-max) Variance Signifi-
cance
Ascorbic acid CG1 27.2 (20.4) 23.1 (1.0-92.7) 416.3 0.056
IG2 34.2 (21.1) 32.0 (1.6-96.0) 444.9
25-OH-D33 CG 44.8 (25.5) 35.8 (13.2-128.9) 652.7 0.020
IG 51.9 (23.7) 47.8 (14.6-134.9) 562.9
Glutathione CG 3.76 (1.98) 3.60 (0.36-9.00) 3.94 0.503
IG 4.07 (2.36) 3.96 (0.32-14.99) 5.57
1 Control Group
2 Intervention Group
3 25-Hydroxycholecalciferol
Table 5.6: Number of patients with micronutrient concentra-
tions below references for healthy people
Micronutrient <Reference
IG2
<Reference
CG1
Significance
Ascorbic acid5 17/66 26/66 0.137
25-OH-D33 7/66 9/66 0.791
25-OH-D34 56/66 58/66 0.800
Glutathione6 16/66 17/66 1.000
1 Control Group
2 Intervention Group
3 25-Hydroxycholecalciferol, reference level:25 nmol/l
4 Reference level: 80 nmol/l
5 Reference level: 17 µmol/l
6 Reference level: 2.2 µmol/l
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5.3 Micronutrient therapies during hospitalisation
Different preparations of micronutrients were prescribed by the physicians independently
of the study. However, compliance was not evaluated. Four patients (CG: 1, IG: 3;
p=0.619) received ascorbic acid supplementation (a multivitamin pill with 180 mg ascor-
bic acid per day). Vitamin D was prescribed to 23 patients (CG: 10, IG: 13; p=0.647)
as a combination preparation (500 mg calcium and 400 I.U. 25-OH-D3 per day). Other
vitamins were prescribed to 10 patients in each group (p=1.000) and minerals to 58
patients (CG: 31, IG: 27; p=0.599).
5.4 Nutritional interventions during hospitalisation
On every study day patients in IG consumed more energy and protein than patients in
CG (refere to figure 5.2, next page). The repeated measure AONVA revealed a highly
significant intervention effect for both protein and energy intake (p<0.001) after 5 and
10 days of intervention (see table 5.7).
Table 5.7: Intervention results
Variable Randomi-
sation
Mean (SD) Median (min-max) Variance Significance
rmANOVAa
Kcal/d CG1 1115 (381) 1110 (485-2269) 145162 <0.001b
IG2 1553 (341) 1518 (789-2827) 116586
Protein/d CG 43.9 (17.2) 44.8 (16.3-103.8) 296 <0.001b
IG 65.4 (16.4) 65.7 (26.8-102.2) 270
1 Control Group
2 Intervention Group
a Repeated measure ANalysis Of VAriance
b Intervention periods 5 and 10 days (with n=119 and n=70, respectively)
The nutritional interventions led to a significant higher absolute mean intake of energy
and protein per day in IG compared with CG patients (table 5.7). The energy (IG: 24
(8) kcal/kg vs. CG: 18 (7) kcal/kg) and protein intakes (IG: 1.0 (0.3) g/kg vs. CG:
0.7 (0.3) g/kg) also differed significantly (p<0.001) when expressed as calories and gram
protein per kg body weight. 55 patients (83%) in IG and 20 (30%) in CG reached a
mean daily energy intake equal or above the 75% threshold of their individual estimated
TEE. However, the mean estimated TEE was 175 kcal in IG and 618 kcal in CG higher
than the actual mean daily caloric intake (both values p<0.001).
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Figure 5.2: Caloric (A) and protein (B) intake according to randomisation (Control
Group: shadowed bars, Intervention Group: white bars)
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5.4 Nutritional interventions during hospitalisation
All patients in IG had at least one meal during their hospitalisation which was con-
sumed less than 75% (see methods). ONS and/or in-between meals were therefore offered
according to the patients’ preference and compliance. In total, ONS covered 13 (11)% of
protein and 9 (8)% of energy in IG and 3 (11)% of protein and 2 (8)% of energy in CG
(for both values p<0.001 between groups). The main coverage of energy was achieved
by normal food in both IG (86 (9)%) and CG (95 (11)%, p<0.001). The same applies to
the total daily protein intake which was primarily covered by normal food (IG: 82 (12)%
vs. CG: 96 (12)%, p<0.001). It contributed to energy supply by 18 (2) and 17 (3)%
(p=0.008) in IG and CG, respectively. Regarding normal oral food only, the intake was
highly significant between groups for both, energy and protein intake (see figure 5.3 and
A.7).
Figure 5.3: Caloric intake according to food type/intervention
In IG 27 (8) % of the total energy and 27 (10) % of the total protein was consumed
as in-between snacks. For CG numbers were 11 (10) % and 9 (12) %, respectively, both
differences highly significant between groups (p<0.001). The energy and protein intake
were significantly different between groups at all meals except breakfast and a trend-like
difference only at supper (see figure 5.3 and A.7).
Apart from ONS food fortification, enteral nutrition and intra-venous glucose/fat sup-
ply did not contribute considerably to nutrient intake (see table A.1 and A.2). In IG
all but two patients received food fortification whereas only 12 control patients received
fortified food by either the dietician or with milk shakes (standard fortified; p<0.001).
Only three patients received enteral nutrition (CG: 1, IG: 2, p=1.000). Parenteral sup-
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ply (which was not meant to nourish the patient, i.e. 5 % glucose, ”Misch 2:1”- infusion
and propofol injection) was responsible for a low percentage of total calorie supply in 45
patients (IG: 1 (2) %, CG: 2 (5) %; p=0.023).
Figure 5.4: Caloric (A) and protein (B) intake according to meals
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5.5 The compliance of ONS intake
In IG, 59 patients received standard ONS during hospitalisation. Six patients received
lipid-free ONS due to a contraindication (e. g. fat malabsorption due to pancreatitis).
One patient did not obtain any ONS due to organisational problems. In CG, nine pa-
tients received ONS (prescribed by the physician) independently of the 75 % intervention
algorithm. One patient showed a contraindication for standard ONS and 56 did not re-
ceive ONS. Compliance was analysed for standard ONS only. In all patients receiving
standard ONS (both in CG and IG), ONS supplied 10 % of the energy and 15 % of the
protein. Thereby, only half of the volume which was prescribed was consumed (median
(minimum-maximum): 51 %, 0-100 %). There were 40 % of the patients taking less
than one quarter. 9 % took 25 to 49 %, 16 % consumed 50 to 74 % and 35 % finished
three quarters or more. Patients’ compliance scores (see methods) were as follows: score
1 (low compliance): 27 %, 2: 15 %, 3: 16 %, 4: 25 %, 5 (high compliance): 18 %.
Median compliance score was 3 (1-5). This score correlated with the consumed volume
(r=0.94; p<0.001). Comparing the patients with a high ONS compliance to those with
low compliance (ignoring randomisation pattern) there were no differences in the major
outcome variables (i.e. body weight, difference in body weight, complications, antibiotic
therapies, quality of life, re-hospitalisation within six months and death during and six
months after hospitalisation). However, the patients who consumed at least half of the
ONS showed a trend towards a higher kcal intake compared with the patients with low
ONS compliance (1609 (355) kcal vs. 1429 (396) kcal, p=0.052). A significant difference
was found regarding the ascorbic acid plasma levels at discharge (50.9 (21.7) µmol/l
vs. 39.3 (31.0) µmol/l, p=0.023) and the mean daily protein intake (71.6 (16.6) g vs.
57.2 (17.4) g, p<0.001). Also, the compliance score (4.2 (0.7) vs. 1.6 (0.7), p<0.001)
and the ONS volume that was consumed (83 (17) % vs. 17(14) %, p<0.001) differed
between groups. Except for the afternoon and bedtime snack there were no differences
concerning energy and protein intake at every meal. Since ONS were served at snack
time basically, patients taking less than 50 % of ONS had lower intakes at in-between
meals.
5.6 The nutritional status
5.6.1 The developement of the body weight
The body weight and the BMI at discharge were similar between groups (table 5.9).
Considering weight change (from ward admission to discharge), patients of IG were
able to keep their body weight (admission: 68.1 (16.9) kg vs. discharge: 68.1 (15.9)
kg, p=0.967) in contrast to CG patients (admission: 66.1 (16.2) kg vs. discharge: 64.7
(16.0) kg, p=0.002). Thus, a significant difference in weight change was observed between
groups(CG: -1.4 (3.2) kg, IG: 0.0 (2.9) kg; p=0.008; table 5.9).
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5.6.2 The developement of micronutrient serum parameters
Serum parameters of ascorbic acid, glutathione and 25-OH-D3 showed different patterns
(table 5.8). At discharge, ascorbic acid plasma levels were higher in IG (46.7 (26.7)
µmol/l) than in CG (34.1 (24.2) µmol/l, p=0.006) due to a larger increase (+12 µmol/l
vs. +7 µmol/l) over time. With respect to glutathione an intervention effect was not
visible. Compared to admission, discharge levels were unchanged (IG: 3.94 (1.89) µmol/l
vs. 3.69 (2.16) µmol/l, p=0.407). Similarly, 25-OH-D3 admission levels repeated at dis-
charge with almost the same group difference (IG: 51.4 (24.2) nmol/l vs. CG: 44.4 (26.4)
nmol/l, p=0.017). Applying these analyses to the subgroups without supplementation,
i.e. without ascorbic acid, 25-OH-D3 or other vitamins supplementation (s.o.), results
were the same. Referring to references for healthy people there were fewer patients with
low plasma levels for ascorbic acid at discharge (i.e. 23 %; 27/115) and a trend for a
difference between groups existed (IG: 10/61 vs. CG: 17/54, p=0.078). With 25-OH-
D3, 14 % (16/115) of patients had low plasma concentrations (IG: 4/60 vs. CG: 12/55,
p=0.029). Referring to the 75 nmol/l reference, even 86 % (99/115) showed low 25-OH-
D3 concentrations (IG: 52/60 vs. CG: 47/55, p=1.000). Low glutathione concentrations
affected 28 % (32/114) of the patients at discharge (no group difference). A seasonal
influence of UV-B radiation in sun light on vitamin D production was not observed
between patients’ blood drawn from September to March and April to August.
Table 5.8: Number of patients with micronutrient concentra-
tions below references for healthy people (discharge)
Micronutrient <Reference
IG2
<Reference
CG2
Significance
Ascorbic acid5 10/61 17/54 0.078
25-OH-D33 4/60 12/55 0.029
25-OH-D34 52/60 47/55 1.000
Glutathione6 14/60 18/54 0.298
1 Control Group
2 Intervention Group
3 25-Hydroxycholecalciferol, reference level: 25 nmol/l
4 Reference level: 75 nmol/l
5 Reference level: 17 µmol/l
6 Reference level: 2.2 µmol/l
5.7 The SF-36 quality of life at discharge
Two physical scales (the physical function subscale (CG:36 (26) %, IG: 51 (26) %) and
the physical summary component (CG: 32 (9) %, IG: 37 (11) %)) of the quality of life
SF-36 score showed significant differences between groups at discharge (for details refer
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to figure 5.5 and table A.3). Additionally, one subscale showed a trend in differences,
i.e. the second subscale (role-physical). All of the differences had clinical significance,
since a clinically relevant effect size was defined as a minimum difference of five percent.
All scales related to mental health did not show any differences between groups.
Figure 5.5: SF-36 Physical Component Summary
5.8 Morbidity and Mortality during hospitalisation and
follow-up
The number of patients suffering from in-hospital complications was lower in IG than
in CG (4/66 vs. 13/66, p=0.035). Complications in IG were infections of unknown
aetiology (n=2), urinary track infection (1) and decompensate congestive heart failure
(1). In CG complications were: urinary track infection (5), septic arthritis (1), decubitus
(1), diarrhoea (1), myocardial infarction (2), decompensated congestive heart failure
(1), thrombosis (1) and cerebrovascular ischemia (1). Consequently, antibiotics for the
treatment of infectious complications were more often prescribed to patients of CG than
IG (IG: 1/66 vs. CG: 8/66; p=0.033). After a censoring for death (i.e. the same
analysis without patients who died during hospitalisation), the number of complications
and antibiotics only showed trends in differences. In IG, 4 of 64 and in CG 10 of 61
patients had complications (p=0.092). Antibiotics were prescribed to 1 of 64 patients
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(IG) and 6 of 61 (CG, p=0.058). Neither length of ward stay (possible (LOSg) and
definite (LOSh), respectively) nor length of hospital stay (LOSi) differed between groups
(table 5.9). Six months after discharge patients of CG were more often re-hospitalised
than patients of IG (IG: 17/64 vs. CG: 28/61, p=0.027). During the study period, seven
patients died (5 in CG and 2 in IG, p=0.440). During follow-up, 15 patients died (6/61
in CG and 9/64 in IG; p=0.585).
Table 5.9: Further outcome data
Variable Randomi-
sation
Mean (SD) MD (min-max) Variance Significance
LOSg CG1 14.9 (10.2) 13 (4-63) 104.0 0.458
IG2 13.8 (7.1) 12 (3-38) 50.0
LOSh CG 15.9 (10.7) 13 (4-63) 113.5 0.843
IG 15.7 (9.2) 13 (3-42) 84.1
LOSi C 18.6 (17.1) 14 (4-120) 293.5 0.913
IG 17.0 (10.4) 13 (3-48) 107.4
Body weight CG 64.7 (16.0) 62.2 (29.6-99.9) 256.9 0.227
IG 68.1 (15.9) 66.0 (41.6-109.9) 252.2
Difference CG -1.4 (3.2) -0.8 (-13.5-4.8) 10.2 0.008
body weight IG 0.0 (2.9) 0.0 (-9.1-7.4) 8.4
BMI3 CG 23.6 (4.9) 23.4 (13.2-42.7) 24.4 0.147
IG 24.6 (4.9) 24.5 (16.3-36.7) 23.9
g Ward admission to possible discharge
h Ward admission to definite discharge
i Hospital admission to discharge
1 Control Group
2 Intervention Group
3 Body Mass Index
5.9 Per-Protocol analysis
Data was analysed according to ”Per Protocol” as well and revealed no differences in
outcome parameters in comparison to the Intention-To-Treat analysis (see appendices
A.5).
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The following chapter summarises the main results of the study and compares them to
results of similar investigations. The scope of the results is discussed in the light of
study limitations. Finally, conditions are specified under which the implementation of
our study strategy might be especially successful.
6.1 Main results of this study in the light of current evidence
This study strongly confirms that an individual nutritional intervention, even during a
short-term stay, can improve the outcome in hospitalised patients already malnourished
or at risk to develop malnutrition in a general medical ward. Since the study design
was based on a decisive algorithm (15 % increased calorie intake) and the nurses and
physicians of the ward were not informed about group allocation, the beneficial effects
on body weight change, complication incidence, antibiotic description, quality of life
and ascorbic acid plasma concentration are due to an increased macronutrient (energy)
and micronutrient intake. Additionally, the findings support the malnutrition screening
by NRS-2002 in general medical wards as it selected the patients who profited from
nutritional support in our study.
6.1.1 Multi-factorial nutritional support in other investigations
In three previous intervention studies an individual multi-factorial intervention was less
effective than our clinical trial with respect to patient outcome. Hickson et al. [201,
278] designed a randomised controlled mono-centre trial with the aim of investigating
the effect of nutritional interventions on nutritional status (BMI, body weight, mid
arm (muscle) circumference, triceps skin fold), infection rate, fluid and antibiotics use,
functionality (Barthel Score, hand grip strength), plasma albumin, LOS and mortality
rate. 592 general medical patients being 65 years and older and unspecific in terms
of nutritional risk were randomised to either standard care or additional nutritional
support. Interventions (limited to lunch and dinner servings) were conducted by a health
care assistant (additionally to ward staff) on each of three different wards during five days
a week. The assistants were taught in nutritional care before the start of the study. The
study design focused on optimizing nutritional intake. Interventions included individual
feeding support, motivation to eat, monitoring intake, solving feeding problems, offering
additional snacks and drinks. Details with respect to nutritive measures and individual
care were not given. Both, the energy (1288 kcal vs. 1376 kcal, p=0.53) and protein
intake (47 vs. 50 g, p=0.62) were numerically higher in IG. This difference was, however,
not significant. All primary goals were the same in the two groups. Patients in IG
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depended fewer days on intravenous antibiotics (p=0.007) but information on disease
severity was not given.
Johansen et al. [198] investigated 212 internal and surgical patients (mean age 62
years, malnourished according to NRS-2002) in a randomised controlled multi-centre
study. The intervention measures were performed and guaranteed by a team of a nurse
and a dietician at each hospital and included: motivation of staff and patient to follow
eating behaviour, adjustment of a nutritional plan on estimates of daily energy and
protein needs, and recording of 24h-dietary intake. The results revealed that 62 % of
patients of the intervention group and 36 % of the control group covered 75 % or more of
their estimated energy requirements. In our study energy coverage of at least 75 % was
achieved by 83 % of IG patients. In CG 30 % of the patients managed to reach the 75 %
target or more of their individual energy requirements. Regarding outcome parameters
body weight change did not differ between groups (-0.22 (0.54) kg vs. 0.10 (0.31) kg)
in the Johansen study. In contrast, we detected a significant 1.4 kg loss of body weight
in CG patients compared to IG patients. Therefore, weight change still seems to be
a marker of the nutritional status although one has to allow for patients with cardiac
heart failure. In the present study 37 % of all patients (no difference between groups)
lost body weight due to diuretics therapy of hyperhydration. Johansen et al. published
a general LOS (mean (SE): 17 (2) vs. 22 (2) days, p=0.028) and a specific LOSNDI (LOS
Nutritional Discharge Index; 14 (2) vs. 20 (2) days, p=0.015), which were significantly
different only in the subgroup of patients with complications. The LOS in our study
was longer in CG compared to IG but without any significant difference. In comparison
to other studies the LOS reported here is rather short [121]. If there had been an effect,
the number of patients would have been too low to show it. However, our findings agree
well with the study of Johansen et al., who reported a difference of LOS of one day in
the total study population. Since there were too few patients with complications in our
study, LOS was not analysed in this subgroup. Furthermore, Johansen et al. showed no
effect on the quality of life according to SF-36. In malnourished out-patients (defined by
SGA) QoL improved significantly [152]. In malnourished surgical patients QoL improved
significantly in the intervention group who received oral supplements [279]. Equally, the
SF-36 scales related to function improved clinically relevant, i.e. a minimum 5 % change,
in IG patients in our study. Functionality is a parameter which is affected by nutritional
deficiencies early [111]. On the other hand it reacts quickly to the reversion of a depleted
status [173]. As a better functionality was related to a higher degree of fat-free mass
[280], we assume that the conservation of body weight in our study was at least partly
due to the conservation of fat free mass.
The third study by Duncan et al. [199] investigated whether the support by dietetic as-
sistants improved the energy and protein intake and subsequently the nutritional status,
LOS, complication rate and the mortality in hip fracture patients. 318 women aged 65
years and older were randomised to either standard or additional care by dietetic assis-
tants. Both groups received oral nutritional supplements. The interventions consisted of
checking food preferences, co-ordinating appropriate meal orders, ordering ONS, provid-
ing feeding aids, assisting and encouraging during feeding and support of the specialist
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dietetic assistants. A detailed feeding algorithm was not available. The energy intake
in the ”assistants group” was higher than with standard care (1105 kcal/day vs. 756
kcal/day, p<0.001). In contrast to our interventions, normal hospital food intake was
not significantly higher in the ”assistants group”. However, the difference in the total
daily energy intake was due to a higher ONS intake (409 kcal/day vs. 123 kcal/day,
p<0.001). Moreover, the decline of mid arm circumference was significantly less in the
”assistants group” (-0.89 cm vs. -1.28 cm, p=0.002). However, complication rate, LOS,
body weight, triceps skin fold and serum parameters (serum albumin, haemoglobin, lym-
phocyte count) did not differ between the groups. This is partly in contrast to our results
- probably due to a different study population and a lower mean total energy intake.
We observed a significantly higher number of new complications among those infectious,
which were more often treated with antibiotics in CG than in IG. Complications might
have fatal consequences [281]. Also, our study did not aim at showing causal relations
between the severity of complications and mortality. However, the number of patients
with complications was no more statistically different after the data had been censored
for death. Besides, readmission rates within six months were twice as high in CG than in
IG. Twenty-eight out of 61 patients (46 %) in CG and 17 out of 64 patients in IG (27 %)
were re-hospitalised. This agrees with studies in the ambulant setting [173, 131]. Duncan
et al. reported fewer deaths in both the trauma unit (10.1 % vs. 4.1 %, p=0.048) and at
4 months after discharge (22.9 % vs. 13.1 %, p=0.036) while hospital mortality did not
differ significantly. There was no difference between groups in either period of time, i.e.
within hospitalisation and during follow-up, in our study. This applies to most studies
since a causal relationship was rarely reported. [179, 282, 283]. However, some studies
show an effect of nutritional support on mortality. There, the intervention periods were
mostly longer [188, 284, 285] and patients were more seriously ill than those in our study
[286].
6.1.2 Intervention efficiency in different study settings
As shown above, the influence of nutritional support on the outcome is still inconsistent.
The different levels of intervention efficiency may explain these differences. It has been
shown for cystic fibrosis patients that outcome improves dependent on the extent of en-
ergy delivery [287]. In contrast, it is not easy to provide patients with the complete and
effective intervention [200, 288]. A tight feeding algorithm as applied in our study may
thus be beneficial in order to achieve a high feeding quality and efficiency. Furthermore,
we designed our study to avoid much heterogeneity in order to facilitate the detection of
differences in the outcome. We limited heterogeneity of both the patient group consid-
ered (only medical patients), the setting (one hospital, one ward) and the interventions
(one person applying the nutritional support, similar amount of personal attendance in
both groups). The interventions were further limited to patients who were most likely
to profit from nutritional support (i.e. patients being at risk of malnutrition according
to NRS-2002 and not having the manifested disease yet; exclusion of terminal patients).
As indicated in table 6.1 the study settings of the above cited intervention studies
vary. The studies by Hickson and Frost [289] was the largest of these studies but did not
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reach the minimum effect size of the nutritional intervention. Additionally, although the
elderly are especially at risk of malnutrition, risk patients were not defined. The study by
Johansen et al. [198] probably had too much statistical noise to elucidate more outcome
differences. As patients in three hospitals with different specialities were recruited and 6
persons were applying the intervention, the study setting may have been to heterogenous.
The study by Duncan et al. [199] was performed at one study ward by two dieticians.
Besides, more than 300 patients were recruited (which may have complicated a more
successful intervention). In spite of that, the study setting was more homogenous than
with Hickson et al. or Johansen et al. Additionally, the study patients (operated at
a trauma ward) may have been more prone to nutritional support due to more severe
illness which may be the reason for the improved mortality rate in the intervention group.
Table 6.1: Key parameters of multifactorial nutritional intervention trials
Parameter Hickson et al. Johansen et al. Duncan et al. Starke et al.
No. of wards/
hospitals
3/1 3/3 1/1 1/1
Departments medical for
elderly
surgical and
medical
trauma (hip
fracture)
medical
No. of patients 592 212 3181 132
Mean age 82 62 84 72
Nutritional
status
not specified NRS-2002≥3 not specified NRS-2002≥3
Intervention
performer
3 3x2 2 1
Effect size
energy
n.s. 285 kcal/d 349 kcal/d 438 kcal/d
Effect size
protein
n.s. 11.5 g/d - 21.5 g/d
Mean energy
intake IG/CG
23/22 kcal/kg 30/25 kcal/kg 19/13 kcal/kg3 24/18 kcal/kg
Mean protein
intake IG/CG
0.8/0.8 g/kg 1.1/0.9 g/kg - 1.0/0.7 g/kg
Improved
Outcome2
n.s. LOS
(complication)
MUAC,
mortality
Body weight
change, QoL,
complications,
antibiotic
therapies,
readmissions
1 women only, 2 all ITT analysis, 3 third post-operative day
Unfortunately, the cited studies did not describe details of the nutritional intervention
proceedings. Hickson et al. reported a difference in the energy intake of 88 kcal/d, which
40
6.1 Main results of this study in the light of current evidence
might be too low to show any effect on the outcome. Either the educated assistants
were not trained enough, or it was insufficient to employ them only during the week or
elderly patients do not respond to nutritional interventions. Additionlly, the standard
energy intake (i.e. the energy intake of CG) was close to normal, which complicated
a significant intervention effect. Johansen et al. reached the difference we intended
to achieve, i.e. about 285 kcal/d (see power calculation). This amount seems to be
the minimum difference related to a change in outcome parameters according to the
literature [15]. However, Duncan et al. reported a difference (349 kcal/d) which was
above this minimum and due to a higher ONS consumption. With 438 kcal/d the
difference achieved in our study was even higher and normal food contributed to the
largest part of energy and protein intake. Protein values were often reported in relation
to the energy intake. A quite small difference with Hickson et al. (3g/d) was surpassed
by Johansen et al. (11.5 g/d). The difference in the present study amounted to 21.5 g/d.
However, the energy percentage presented by protein intake was similar in all studies,
i.e. 16 % to 18 %.
6.1.3 Food compounds possibly involved in the conservation of nutritional
status
The main proportion of energy and protein was delivered by normal food in both of
our study groups. In IG, ONS only covered a low percentage of energy and protein
because of a low compliance. Food fortification often has limitations due to the amount
of maltodextrin, protein powder or oil that is miscible with normal food. It also played
a minor role in our study. A better option to increase food intake is the supply of in-
between snacks since patients often wrangle with portion sizes. Up to 25 % of the daily
energy was supplied by these snacks in former studies [290] which was similar to our
results (i.e. 27 %). However, it was difficult to attribute the effects on outcome to one
or more of the food components, i.e. macronutrients and/or the group of micronutrients
and/or energy per se as will be discussed in the next section.
The role of macronutrients and energy
The development of body weight is mainly influenced by the intake of energy per se.
Adiposity research has demonstrated that the amount of energy and not the macronu-
trient distribution is responsible for weight gain or loss [291]. A low energy intake, i.e.
less than 75 % of the individual TEE, was associated with weight loss in hospitalised
patients [72]. Hypermetabolism induced by the disease may require more total daily
energy. Especially, an accelerated protein turnover and muscle breakdown have been
described [98] which might be stopped or reversed by a sufficient protein intake. In
contrast, protein can inhibit the appetite, which may be counterproductive in malnour-
ished patients [292, 293]. Whether the quantity of protein is important without the
relevant amount of calories is discussed vehemently especially when referring to hunger
or catabolic conditions [260, 261]. Additionally, fat-free mass is an important predictor
of REE. Thus, the success of nutritional interventions might depend on the extent of
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disease-related cachexia or age-related sarcopenia apart from age and disease itself.
The role of micronutrients
The risk of developing multiple micronutrient deficiencies is high both with age and
during disease [294, 295]. Thus, the impact of multiple micronutrient deficiencies on
immunity was most obvious in infectious complications [296]. A lack of energy and
protein is accompanied by a deficit in micronutrients [294] especially when total food
intake is decreased. At admission one third of our patients (43/132) showed ascorbic
acid values below the reference level of healthy people (17 µmol/l). Referring to 25-OH-
D3 (25 nmol/l), 12 % (16/132) and to glutathione (2.2 µmol/l) one quarter (33/132) of
the patients had low levels (no differences between groups). Referring to a 25-OH-D3
level of 75 nmol/l [297], 86 % (114/132) of the patients had lower levels at admission.
The high prevalence of 25-OH-D3 deficiency is in line with a publication showing that
25-OH-D3 deficiencies have been related to several disease conditions apart from the
bone metabolism [298]. Besides, the precursor skin production is reduced in the elderly.
Additionally, both the elderly [299] and the ill [300] are less mobile and often home-bound
supporting the high deficiency prevalence that was found in the present study. As oral
food intake contributes only little to the body’s 25-OH-D3 content it is not surprising
that no intervention effect was observed. Even with 17 % of the patients who received
vitamin D treatment (i.e. 400 I.U./d) no effect on plasma levels was recorded. This is
probably due to the low doses (half as much of what is recommended). An amount of
400 I.U. was recorded to raise plasma levels by 5 to 10 nmol/l, which agrees with our
analyses in supplemented patients (results not shown).
The deficiency prevalence was low regarding vitamin C and its measurable metabolites
((mono-) dehydro) ascorbic acid. In serum levels the reduced metabolite dominates
[301]. Likewise, the reduced metabolite is decreased during disease and age in favour of
its oxidative equivalent [302, 303, 304]. Since fresh fruit is available all year round it is
easy to keep a balanced ascorbic acid serum concentration. Nevertheless, serum levels
may react quickly to a decreased or interrupted supply as well as to replenishment in a
deficiency condition [305]. How the active replenishment with single micronutrients in
the hospital setting affects the outcome is mainly unclear. One study showed that early
administration of ascorbic acid and α-tocopherol reduced organ failure and LOS in ICU
in critically ill patients [306]. The intervention effect on ascorbic acid levels may thus
have contributed to the better outcome in our study.
The tripeptid glutathione is involved in many processes during both normal and dis-
ease metabolism [307]. Its main task is to keep a stable level of reduced metabolites and
the balancing of redox processes in the metabolism. Therefore, it interacts with many
other components and molecules, e.g. antioxidants [308]. Its precursors i.e. glutamine
and cysteine obtained importance as they limited glutathione synthesis especially in crit-
ically ill patients [309]. Thus, an influence of amino acid intake on glutathione synthesis
might be possible as has been shown with healthy people during adaption to a lower
protein intake, i.e. a negative nitrogen balance [310]. However, an intervention effect
with the present study population has not been observed.
42
6.2 Limitations of the study
In our study food quality was chosen to be high. For instance, in-between meals com-
bined a micronutrient source (e.g. fruit salad) and protein- and energy-dense components
(e.g. full cream yoghurt). The advantages related to ”normal complete food” have not
been much investigated until now. However, there is knowledge from other nutritional
sectors. The health effect of fruits and vegetables was not validated by the intake of
artificial vitamins [311, 312, 313]. Another example is the advantage of breast-milk
compared to bottled milk [314]. The concerted action of micronutrients (e.g. thiamine)
and proteins (e.g. transketolase [315]) in energy metabolism underlines the importance
of a sufficient intake of both micronutrients and macronutrients. Natural food may thus
be beneficial because of an optimal ratio of all compounds. In addition, they contain
immuno- and antioxidatively active compounds (e.g. secondary plant micronutrients)
which are not available in designed food or even unknown up to now.
Since ascorbic acid serum concentrations have been influenced by our interventions
other micronutrient concentrations (which we did not analyse) may have been affected
as well. Therefore, the increased micronutrient concentrations may have contributed
to the outcome benefits beside the mere effect of a higher caloric and protein intake.
Recently a British study showed that ONS increased vitamin serum levels in comparison
to ”low-quality” snacks (e.g. puddings, biscuits etc. [188]). In the group supplemented
with ONS (in that study the more valuable nutrient source) even fewer complications
were recorded [188]. The quality of food may hence be important apart from food
quantity.
6.2 Limitations of the study
Our results have to be interpreted in light of some limitations related to the design of
our study. We decided not to exclude patients at malnutrition risk sharing a room with
a patient randomised to the opposite study arm because of limited human resources.
However, this situation occurred only five times. These patients were easily treated
according to the study protocol as they did not interact. Therefore, we assume that
they did not influence each other although we can’t prove that. Additionally, patients
sharing a room might not have negatively influence our study in terms of a ”Good Clinical
Practice” since a CG patient might have been influenced to eat more or an IG patient to
eat less. In both cases, however, our intake difference would have been less thus reducing
the chance of observing a difference in the outcome. Additionally, personal attendance
might lead to higher food intake. Hence, we tried to balance personal attendance in
the study groups although we did not measure attendance time. The mental scales of
the SF-36, however, may be a surrogate parameter describing the influence of personal
attendance [316]. They did not differ between groups.
There were more female but younger patients in IG. Although these differences were
not statistically significant they should be considered as a heterogeneous study group
decreases the chance of finding small differences. Females eat less than men [317] and
older people eat less than younger people [105]. The effect on the intervention - if any -
might therefore be balanced.
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The main limitations of our study are connected to the study power. Preferred out-
come parameters like morbidity (including hospital-acquired complications), LOS, qual-
ity of life or mortality are often influenced by other factors than nutrition alone. There-
fore, interventions in large trials, e.g. multicentre studies, are needed to confirm relevant
differences between nutritional support and standard care. However, a large randomised
controlled trial complicates intervention homogeneity and the detection of causal rela-
tions. Whether randomised controlled intervention trials only shall be considered the
”gold standard” in order to investigate causal relations between nutrition and the out-
come is questioned and discussed elsewhere [318, 19, 269, 319]. Although the difference
in complication incidence is significant (p=0.035), our study was not powered to statis-
tically confirm a causal relation to nutritional intervention. However, other causes to
explain the differences were hard to define.
6.3 Relevance of the results for the practical implementation
The results of our study apply to patients with a malnutrition risk according to the
NRS-2002 only. Whether different screening or assessment tools show similar results is
a question of future research. In addition, the question whether the NRS-2002 selects
patients who profit of nutritional support in different (e.g. surgical) departments remains
to be investigated. Our experience with the application of only the NRS-2002 main
screening was however convincing to recommend its use. All but 6 of 767 patients
admitted to the study ward could be screened showing its wide range of application.
In sum, our results are promising but may not be readily transferable to different
hospitals. The medical clinic in Liestal, although belonging to the university hospital
Basel, is rather a secondary care hospital. Especially hospitals of tertiary care (i.e.
university hospitals) may need different strategies due to higher diagnostic and treatment
frequency. Additionally, malnutrition prevalence rates may be higher due to more severe
diseases and frequent readmissions requiring more human resources than in our study.
However, the decentralised ward-based nutritional support as applied in our study may
be especially fruitful in big hospitals.
An advantage for the intervention performance was the in-house kitchen of the hos-
pital. In contrast to extern meal delivery services, the kitchen produced high quality
fresh food and individualised orders were responded to most of the time. Small cakes
or biscuits in plastic packages (a common snack in big hospitals or with extern meal
deliverers) were avoided. Instead, fresh yoghurt, creams or even ice cream with fruit
salad were stored on the ward fridge and finally prepared and offered when the patient
was ready to eat. All food items were standardised available and delivered by the hos-
pital kitchen. Also, main meals were stored on the ward in case a patient was absent at
meal time. As soon as the patient was allowed to eat the meal was heated and offered.
During the study the standard menu ordering system was used in order to not increase
the work load for the kitchen. However, the kitchen staff was always available and open
in case of a few special orders, questions related to ingredients or when food was missing
and needed to be replaced. Additionally, the limited hospital size (399 beds) simplified
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organisational issues and communication. On the ward, physicians, (head) nurses and
therapists were always open to questions or comments on the treatment.
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7 Conclusion and Outline
Our findings responded to the question whether nutritional support on an individual
basis is efficient during hospitalisation. Moreover, a couple of new question arose while
performing the study.
7.1 Conclusion
Medical patients at malnutrition risk profit from nutritional support even during short
hospitalisation periods. They maintain their nutritional status indicated by a stable
body weight and higher concentrations of serum ascorbic acid levels. The functionality-
related quality of life at discharge is better in patients receiving nutritional support in
contrast to risk patients receiving standard care. The incidence of complications and
subsequent antibiotic treatments during hospitalisation were reduced in patients receiv-
ing nutritional support. Additionally, the rehospitalisation rate was only half as high in
IG compared to standard care patients. The NRS-2002 screening was an appropriate
tool to identify those patients who finally profited from nutritional support and can thus
be recommended. We assume that nutritional care has to follow a tight algorithm in or-
der to guarantee that the daily individual needs of energy and protein are covered. The
evaluation of the actual amount of food that is consumed by the patients is necessary in
order to adjust the nutrition on a short-term basis. It appears to be an advantage that
the person responsible for the nutritional support is based on the ward.
7.2 Outline and future research
Although the replication of our findings especially in larger settings may be of impor-
tance, there are some ideas which may be the basis for further trials.
• The developers of the NRS-2002 observed that about one fourth of the patients
were misclassified. In our study, there were also a considerable number of patients
who managed to take enough food in the control group. Thus, they were not reliant
on nutritional support although a risk was detected according to NRS-2002. Future
studies may take this into account in order to define patients who actually profit
from nutritional support more precisely.
• For practical reasons the NRS-2002 main screening may be sufficient to select pa-
tients at malnutrition risk. Probably, the main screening takes not much more time
than the pre-screening. Additionally, it only specifies the pre-screening without
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adding additional information. Then, skipping the pre-screening would probably
safe some time in wards with moderate to high malnutrition prevalence rates.
• Whether the NRS-2002 selects patients of e.g. surgical or geriatric departments
remains to be investigated.
• We defined the intervention targets by estimating the individual TEE. The esti-
mates were, however, significantly higher than the actual daily intakes. Studies in
need for the exact TEE should therefore apply indirect calorimetry and not rely
on regress equations. For intervention studies evaluating the daily food intake this
estimate may still be adequate as the absolute difference to the actual intake was
low even though it was significant (i.e. 175 kcal in IG).
• 14 % of the patients in each group (8 of 66) were included during hospitalisa-
tion. This is of disadvantage for the intervention effect because early interventions
may be more effective. For research reasons one may exclude those patients in
order to quantify the intervention effect more precisely. However, as our study
setting reflects the real situation, we were able to show the efficiency under these
circumstances and thus practicability.
• We assume that the composition of natural food compounds, i.e. macronutrients
in combination with micronutrients is of advantage in malnutrition since most of
the energy and protein was supplied by normal food. In order to identify the
most potent nutrient families or a combination of them influencing the nutritional
status, more investigations are necessary focussing on the comparison of, for ex-
ample, micronutrient-rich vs. micronutrient-poor food compounds. Additionally,
the protein level may be changed (e.g. protein-rich vs. protein-poor). Most inter-
esting would be a comparison of natural food to artificial supplements. Besides, a
definiton of food items that are favoured by the patients can be interesting. Our
experience supports the use of easy-to-swallow fresh fruity food, i.e. joghurt, curd
cheese or ice cream with saisonal fruits and cream. However, we did not analyse
objective data so far.
• Additionally, not only different nutritional strategies but also nutritional support
vs. medical treatment needs to be explored especially considering the patients’
quality of life. The importance of nutrition especially during a treatment may
thus be highlighted.
• In order to gain evidence related to morbidity and mortality multi-centre studies
with large study populations are needed. Such an approach, however, may need
well-trained and experienced investigators performing the intervention in order to
achieve the necessary intervention efficiency.
• Finally, the cost-effectiveness of nutritional support may be of economic interest.
Especially the influence of natural food interests because of its low expense in
comparision to other treatments. Additionally, the possible role of a nutritionist on
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each ward with, for example, high malnutrition prevalence rates may be discussed
since individualised services are connected to human resources. The ward-based
nutritional support may also be compared to the so far common nutrition teams
which are responsible for a whole hospital, often occupied with ambulant dietary
counselling and less well-integrated in the medical operations and structures than
physicians or nurses.
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8 Summary
Malnutrition continues to be a relevant health-care problem accompanying disease and
age. High prevalence rates are especially found among hospitalised patients. Meanwhile,
there is ample evidence that an insufficient nutritional status limits a positive clinical
as well as economical outcome. However, there is still need for intervention studies in-
vestigating causal relations. Additionally, the implementation of nutritional strategies
to treat malnutrition in the hospital setting is a challenge. Therefore, a randomised
controlled intervention study was performed with the aim to develop and evaluate a rou-
tinely manageable concept for an improved nutritional care of malnourished in-hospital
patients.
This study was performed from January 2007 to November 2007 (follow-up until June
2008) until 132 adult patients with a Nutritional Risk Screening (NRS-2002)≥3 were
recruited. Patients with the following conditions were excluded: no I.C., a terminal
condition, an expected stay less than 5 days, previously participating in the study,
being on dialysis, starvation and parenteral nutrition. Patients were randomised to the
intervention (IG) or control group (CG) and thus received either an individual nutritional
support for 5 to maximum 28 days or standard care. The nutritional support comprised
a detailed nutritional assessment, individual food ordering, the visually evaluation of
food intake, food fortifications, in-between snacks, oral nutritional supplements (ONS)
and solving eating problems. Primary endpoints of the study were the mean daily energy
and protein intakes. The change in body weight during hospitalisation, the number of
complications, the number of antibiotic therapies due to infectious complication, the
length of stay, the quality of life according to the SF-36 questionnaire, the readmission
and the mortality rates were considered as secondary endpoints. Additionally, plasma
concentrations of 25-OH-D3, ascorbic acid and glutathione were evaluated. Except of
the energy and protein intake all outcome data were blinded in terms of that physicians
and nurses who were responsible for the outcome did not have access to group allocation.
The overall malnutrition prevalence on the study ward was 32%. All study data was
analysed according to the intention to treat principle. The baseline data was equally
distributed between the study groups. Repeated measure ANOVA showed a highly
significant intervention effect on the energy and protein intake. The mean energy intake
was higher in IG (1553 (341) kcal/d) than in CG (1115 (381), p<0.001). The same
applies to the mean protein intake (65.4 (16.4) g/d vs. 43.9 (17.2) g/d, p<0.001). 55
patients (i.e. 83%) in IG and 20 (i.e. 30%) in CG covered 75% or more of their individual
estimated TEE. The main coverage of energy was achieved by normal food (IG: 86 (9)%,
CG: 95 (11)%, p<0.001). Likewise, protein intake was primarily covered by normal food
(IG: 82 (12)%, CG: 96 (12)%, p<0.001). Protein contributed to energy supply by 18 (2)
and 17 (3)% (p=0.008) in IG and CG, respectively.
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All patients in IG had at least one meal during hospitalisation which was consumed
less than 75%. In-between meals and ONS were therefore offered. ONS covered 9 (8)%
of energy intake and 13 (11)% of protein intake in IG. In CG ONS covered 2 (8) % of
energy and 3 (11)% of protein (p<0.001 between groups). Overall compliance of ONS
intake was 51% and only 35% of the patients took more than three quarters of the
ONS drinks. However, if ONS consumption was successfully, then daily total protein
needs were easier met. In contrast, main outcome parameters (like body weight change,
complication incidence, LOS and QoL) did not differ between patients consuming less
and more than half of the ONS, respectively. In-between meals contributed to energy
intake by 27 (8)% (IG) and 11 (10)% (CG, p<0.001). Similarly, in IG 27 (10)% and
in CG 9 (12)% of the daily protein was covered by in-between meals (p<0.001). The
energy and protein intake was significantly different between groups at all meals except
for breakfast and a trend-like difference only at supper. Apart from in-between meals
and ONS, food fortification, enteral nutrition and intravenous supply were applied but
did not contribute considerably to neither energy nor protein intake.
The nutritional status of IG patients was affected by the interventions. A loss of body
weight was recorded in CG patients (-1.4 (3.2) kg) whereas IG patients kept their body
weight (0.0 (2.9) kg, p=0.008). Additionally, the serum ascorbic acid levels at discharge
were higher in IG (46.7 (26.7) µmol/l) than in CG (34.1 (24.2) µmol, p=0.006) due
to a larger increase over time. In contrast, glutathione and 25-OH-D3 levels did not
change. QoL recorded by the SF-36 questionnaire revealed differences between groups
at discharge. IG patients improved clinically relevant (i.e. at least 5%) in comparison
to CG patients in the physical summary component (i.e. the summary scale describing
functionality) and one subscale related to functionality. Additionally, patients of IG
had fewer hospital-acquired complications (4/66 vs. 13/66, p=0.035) and needed less
antibiotics (1/66 vs. 8/66, p=0.033). In contrast, LOS in the ward and the hospital
did not differ between groups. The same applies to the mortality during hospitalisation
and until 6 months after discharge. However, patients of IG were only half as often re-
admitted compared to CG patients during the 6 months of follow-up (17/64 vs. 28/61,
p=0.027).
In three previous intervention studies an individual multi-factorial intervention was
less effective than our clinical trial. Hickson et al. investigated whether health care
assistants tought in nutrition, can improve food intake and several outcome parameters
in elderly medical patients. Both, the energy and the protein intake were not significantly
higher in the ”assistants groups”. Accordingly, all study endpoints were similar in the
two groups. Johansen et al. investigated whether a team of a nurse and a dietician can
improve food intake in medical and surgical patients. Both, the energy and the protein
intake differed between IG and CG. However, the only outcome parameter that was
influence by the intervention was the LOS in a subgroup of patients who had acquired a
complication during hospitalisation. Neither the body weight change, the QoL nor the
LOS in the total population differed between groups, probably because of a heterogenic
study setting. The third study in a trauma ward revealed that dietetic assistants who
were additionally employed to support the dieticians, can improve the energy intake,
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especially by a higher consumption of ONS. Thus, patients in the ”assistants group”
showed a smaller decline in the MUAC and a lower mortality rate in the trauma ward
and during 4 months of follow up.
Comparing these findings with our trial then the study details reveal that the het-
erogenic settings and interventions may have disclosed nutritional effects due to much
statistical noise. Our trial was planned to avoid much heterogeneity, i.e. there was only
one study ward, one intervention performer and only medical patients. Furthermore
we achieved a high effect size concerning the energy and protein intake due to a tight
feeding algorithm. Additionally, we recruited patients who were most likely to profit
from nutritional support, i.e. showing a malnutrition risk according to NRS-2002 (and
not the manifested disease necessarily). Moreover, the main proportion of energy and
protein was delivered by normal food. Although there is not much evidence related to
the type of intervention so far, this might have been an advantage because normal food
is complete in all types of nutrients and the compliance is high.
In conclusion, our results are promising and the implementation of this nutritional
approach can be recommanded even for larger hospitals as the nutritional support is
ward-based.
53

A Appendices
A.1 Nutritional Risk Screening (Original)
Table 1 Initial screening
Yes No
1 Is BMI o20.5?
2 Has the patient lost weight within the last 3 months?
3 Has the patient had a reduced dietary intake in the last week?
4 Is the patient severely ill ? (e.g. in intensive therapy)
Yes: If the answer is ‘Yes’ to any question, the screening in Table 2 is performed.
No: If the answer is ‘No’ to all questions, the patient is re-screened at weekly intervals. If the patient e.g. is scheduled for a major operation,
a preventive nutritional care plan is considered to avoid the associated risk status.
Table 2 Final screening
Impaired nutritional status Severity of disease (E increase in requirements)
Absent Normal nutritional status Absent Normal nutritional requirements
Score 0 Score 0
Mild Score 1 Wt loss 45% in 3 mths or Food intake
below 50–75% of normal requirement
in preceding week
Mild Score 1 Hip fracture* Chronic patients, in
particular with acute complications:
cirrhosis*, COPD*. Chronic
hemodialysis, diabetes, oncology
Moderate Score 2 Wt loss 45% in 2 mths or BMI 18.5 –
20.5 + impaired general condition or
Food intake 25–60% of normal
requirement in preceding week
Moderate Score 2 Major abdominal surgery* Stroke*
Severe pneumonia, hematologic
malignancy
Severe Score 3 Wt loss 45% in 1 mth (415% in 3
mths) or BMI o18.5 + impaired
general condition or Food intake 0-25%
of normal requirement in preceding
week in preceding week.
Severe Score 3 Head injury* Bone marrow
transplantation* Intensive care
patients (APACHE410).
Score: + Score: =Total score
Age ifZ70 years: add 1 to total score above =age-adjusted total score
Score Z3: the patient is nutritionally at-risk and a nutritional care plan is initiated
Score o3: weekly rescreening of the patient. If the patient e.g. is scheduled for a major operation, a preventive nutritional care plan is considered to avoid the
associated risk status.
NRS-2002 is based on an
interpre-tation of available
randomized clinical trials.
A nutritional care plan is indicated in all
patients who are
quirement is increased, but can be covered by oral diet or supplements in
most cases.
*indicates that a trial directly
supports the categorization of
patients with that diagnosis.
Diagnoses shown in italics are
based on the prototypes given
below.
(1) severely undernourished (score=3),
or (2) severely ill (score=3), or (3)
moderately undernourished + mildly ill
(score 2 +1), or (4) mildly
undernourished + moderately ill (score
1 + 2).
Score=2: a patient confined to bed due to illness, e.g. following major
abdominal surgery. Protein requirement is substantially increased, but can be
covered, although artificial feeding is required in many cases.
Nutritional risk is defined by the
present nutritional status and risk
of impairment of present status,
due to increased requirements
caused by stress metabolism of
the clinical condition.
Prototypes for severity of disease
Score=3: a patient in intensive care with assisted ventilation etc. Protein
requirement is increased and cannot be covered even by artificial feeding.
Protein breakdown and nitrogen loss can be significantly attenuated.
Score=1: a patient with chronic disease,
admitted to hospital due to
complications. The patient is weak but
out of bed regularly. Protein re-
Nutritional Risk Screening (NRS 2002)
420 ESPEN GUIDELINES
Figure A.1: Nutritional Risk Screening 2002 (the Original with the pres-
creening (not used in the study), the final screening and infor-
mation on its application
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A.2 Study sheets
A.2.1 Recruitment list
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Figure A.2: Recruitment list with the following columns: Reg.-Nr.: Registration num-
ber, Eintritt: Date of admission, Pat.-Code: patient registry code, Geb.-
Dat.: date of birth, Ak: exclusion criteria, NRS<3: no malnutrition risk,
NRS>3: malnutrition risk (a) and date of screening (b), Einversta¨ndnis-
erkla¨rung: informed consent, Einschluss: at admission (a), during hospi-
talisation (b) plus date of inclusion, group allocation at admission (a) or
during hospitalisation (b)
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A.2 Study sheets
A.2.2 NRS-2002 admission
Teilpunktzahl Score II:Teilpunktzahl Score I:
Schädel-Hirn-Trauma
Polytrauma 
Schwere Verbrennungen
Knochenmarkstransplantation
Intensivpflichtige Patienten 
(APACHE-II>10)
Schwer
3 Pkt.
Gewichtsverlust >5%/1 Monaten 
oder
BMI <18,5kg/m² und reduzierter 
Allgemeinzustand
oder
Nahrungszufuhr 0-25% des 
Bedarfs in der vergangenen Woche
Schwer
3 Pkt.
Gewichtsverlust >5%/2 Monaten
oder
BMI 18,5-20,5 kg/m² und 
reduzierter Allgemeinzustand
oder 
Nahrungszufuhr 25-50% des 
Bedarfs in der vergangenen Woche
Gewichtsverlust >5%/3 Monaten
oder
Nahrungszufuhr 50-75% des 
Bedarfs in der vergangenen Woche
Störung des Ernährungszustandes (Score I)
Gesamtpunktzahl Score I+II inkl. 1 Alterspunkt (Alter ≥ 70 Jahre):
Mittel
2 Pkt.
Leicht
1 Pkt.
Große Bauchchirurgie
Cerebrovaskuläre Insulte
Schwere Pneumonie
Hämatologische 
Krebserkrankung
Geriatrische Patienten mit 
langer Hospitalisation
Chemotherapie
Mittel
2 Pkt.
Schenkelhalsfraktur
Chronische Erkrankungen mit 
Komplikationen: 
Leberzirrhose, COPD, 
chronische Hämodialyse, 
Diabetes, Krebsleiden
Radiotherapie
Leicht
1 Pkt.
Krankheitsschwere (Score II)
EINTRITT Pat.-Code:
Eintrittsdatum: Zi.: Geschlecht: w       m 
Größe (anam.): Gewicht (anam): Blutabnahme: nein       ja
Größe (gem.): Gewicht (gem.): BMI [kg/m2]*:
Diagnosen: ICD-10-Code:
ICD-10-Code:
ICD-10-Code:
Medikamente:
Gem.=gemessen; anam.=anamnestisch; Pkt.=Punkt/e; Zi=Zimmer
*nur wenn Gewicht nicht ermittelbar, wird der Oberarmumfang (OAU) in cm angegeben
Figure A.3: Modified NRS-2002 admission sheet
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A.2.3 Discharge sheet
AUSTRITT Pat.-Code:
Wiedereintritt: nein      ja      (Dat.:                 ), Tod: nein      ja       (Dat.:                 ) 
Follow Up-Datum:
Compliance: 1) keine       2) schlecht 3) mittelmäßig        4) gut 5) optimal
(Supplement)
Zi.: Austrittsdatum: Tod i. Spital: nein ja    , verlegt: nein ja
Gewicht (gem.): BMI [kg/m2]: Blutabnahmenein       ja
Diagnosen: ICD-10-Code:
ICD-10-Code:
ICD-10-Code:
ICD-10-Code:
Komplikation:
nichtinfektiös
Antibiotika-Therapie
infektiös
Figure A.4: Discharge and Follow-Up sheet
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A.2.4 Nutritional anamnesis
Standardgewicht: kg Kleidung zu gross 
Gewichtsverlust: kg/ Mo Gewichtsanstieg: kg/ Mo
Ernährungsanamnese – Patientenbogen Pat.-Code:
Essverhalten Menge, Lieblings-/ vermiedenes Essen, Dauer falls hypokalorisch, Konsistenz, 
Veränderung zu sonst 
Frstk
Mittag
Abend
Sonstiges
GI-Symptomatik Übelkeit, Diarrhöe, Erbrechen, Dauer, Stuhl, Urin.(KG)
Leistungsfähigkeit Mobilität, Sturzgefahr, Selbständigkeit, Müdigkeit, Schwäche, Angst,…
Klinisches Bild: Ödeme, Aszites, subkutanes Fettgewebe, Muskulatur, Haut, Haar
Medikamente, NEM, sonstige Zusätze
Sonstige Einschränkungen Kauprobleme, Zahnersatz, Dysphagie, Appetitlosigkeit, …
Bedarf: REE: kcal Aktivitätsfaktor:
(Eintritt) Krankheitsfaktor:
Total: kcal/d Protein: g/d
Figure A.5: Nutritional anamnesis applied with IG patients
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A
.2.5
Evaluation
ofinterventions
Pat.-Code:
Interventionstag
Aufenthaltstag Aufenthaltstag
Temp. (erhöht) Mittag
Gewicht
Bedarf (kcal, gProt)
Ödem-Info
Untersuchg. (Zeit)
nüchtern (Mahlzeit)
Fl. i.v. (ml)
Substrat
Supplemente (Resource)
Compliance (1-5)
Vit.-/MS-NEM
EN (Substrat) gesamt
Volumen kcal/Prot.-Menge
Komplikation ZMZ
Anzahl Medikamente
Antibiotika i.v.
Antibiotika p.o. Abendbrot
Frühstück
gesamt
gesamt kcal/Prot.-Menge
kcal/Prot.-Menge ZMZ
ZMZ
Energie (kcal/d)
Protein (g/d)
Temp.=Temperatur; Fl. i.v.=Flüssigkeit intravenös; Vit./MS/NEM=Vitamine, Mineralstoffe, Nahrungsergänzungsmittel; EN=enterale Sondenernährung; p.o.=per os; ZMZ=Zwischenmahlzeit
REE=0.02219xweight+0.02118xheight+0.884xsex-0.01191xage+1.233 (0=female, 1=male)
1 2 3 4 5 54Interventionstag 1 2 3
Figure
A
.6:N
utritionalintervention
evaluation
sheet,one
sheet
per
patient
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A.3 More data related to the ITT analysis
A.3.1 Caloric intake per meal and therapeutic approach
Table A.1: Caloric intake per meal and therapeutic approach
Variable Randomi-
sation
Mean (SD) MD (min-max) Variance Significance
Breakfast CG1 341 (151) 352 (0-676) 22758 0.475
IG2 361 (112) 345 (138-754) 12604
Morning CG 40 (59) 13 (0-304) 3464 <0.001
snack IG 114 (61) 105 (0-295) 3766
Lunch CG 279 (110) 278 (0-495) 12097 <0.001
IG 363 (95) 366 (111-573) 8958
Afternoon CG 57 (68) 33 (0-250) 4590 <0.001
snack IG 172 (70) 165 (0-394) 4947
Supper CG 343 (121) 346 (111-647) 14741 0.064
IG 383 (112) 372 (151-640) 12606
Bedtime CG 32 (50) 8 (0-250) 2486 <0.001
snack IG 133 (73) 118 (0-325) 5259
Enteral CG 1 (12) 0 (0-94) 133 0.549
nutrition IG 17 (120) 0 (0-964) 14490
Fortification CG 2 (5) 0 (0-20) 27 <0.001
IG 59 (40) 49 (0-202) 1639
ONS3 CG 27 (112) 0 (0-750) 12509 <0.001
IG 132 (121) 101 (0-546) 14616
Intravenous CG 22 (48) 0 (0-291) 2317 0.023
supply IG 8 (32) 0 (0-225) 993
1 Control group
2 Intervention group
3 Oral Nutritional Supplements
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A.3.2 Protein intake per meal and therapeutic approach
Table A.2: Protein intake per meal and therapeutic approach
Variable Randomi-
sation
Mean (SD) MD (min-max) Variance Significance
Breakfast CG1 9.7 (4.6) 9.6 (0.0-24.3) 21.5 0.498
IG2 10.2 (3.7) 9.0 (3.4-17.1) 14.0
Morning CG 1.2 (2.9) 0.2 (0.0-19.8) 8.3 <0.001
snack IG 4.2 (3.4) 3.1 (0.0-14.0) 11.5
Lunch CG 14.4 (6.6) 13.8 (0.0-31.5) 44.0 <0.001
IG 19.6 (6.4) 20.0 (6.0-38.3) 41.1
Afternoon CG 1.9 (3.6) 0.5 (0.0-18.8) 13.1 <0.001
snack IG 6.1 (3.0) 5.5 (0.0-14.0) 9.2
Supper CG 15.3 (5.3) 15.5 (4.4-27.6) 27.9 0.050
IG 17.3 (5.9) 17.5 (5.7-30.6) 34.9
Bedtime CG 1.3 (2.8) 0.0 (0.0-18.8) 8.1 <0.001
snack IG 7.4 (4.9) 6.5 (0.0-20.8) 23.6
Enteral CG 0.1 (0.5) 0.0 (0.0-3.8) 0.2 0.991
nutrition IG 0.6 (4.7) 0.0 (0.0-038.6) 22.5
Fortification CG 0.3 (0.9) 0.0 (0.0-4.8) 0.7 <0.001
IG 2.7 (2.1) 2.3 (0.0-9.8) 4.3
ONS3 CG 1.9 (7.9) 0.0 (0.0-56.4) 63.2 <0.001
IG 8.7 (7.5) 6.5 (0.0-25.6) 56.2
Intravenous CG substrates did not contain
supply IG any proteins
1 Control Group
2 Intervention Group
3 Oral Nutritional Supplement
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A.3.3 Protein intake according to food type/intervention
Figure A.7: Protein intake according to food type/intervention
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A.3.4 SF-36 outcome data
Table A.3: SF-36 outcome datab
Scalea Randomi-
sation
Mean (SD)c Median
(min-maxc)
Variance Significance
SF-36 PF CG1 36 (26) 35 (0-85) 671 0.012
IG2 51 (26) 50 (0-100) 699
SF-36 RP CG 19 (36) 0 (0-100) 1283 0.051
IG 33 (42) 0 (0-100) 1761
SF-36 BP CG 67 (30) 72 (0-100) 898 0.845
IG 66 (33) 74 (0-100) 1117
SF-36 GH CG 53 (17) 55 (10-92) 293 0.186
IG 59 (22) 65 (15-97) 488
SF-36 VT CG 39 (17) 35 (5-85) 287 0.978
IG 40 (24) 40 (0-90) 561
SF-36 SF CG 79 (23) 88 (25-100) 543 0.977
IG 78 (26) 88(0-100) 661
SF-36 RE CG 67 (44) 100 (0-100) 1944 0.365
IG 72 (44) 100 (0-100) 1951
SF-36 MH CG 70 (18) 72 (12-100) 331 0.784
IG 71 (19) 72 (24-100) 366
SF-36 PCS CG 32 (9) 30 (19-56) 74 0.033
IG 37 (11) 35 (15-65) 119
SF-36 MCS CG 51 (11) 53 (22-72) 115 0.640
IG 50 (11) 52 (25-66) 112
a SF-36 abbreviations: PF-Physical Function, GH-General Health, RP-Role Physical,
BP-Bodily Pain, SF-Social function, RE-Role emotional, MH-Mental Health, VT-
Vitality, PCS-Physical Component Summary, MCS-Mental Component Summary
b for all SF-36 sub- and summary scales: n=49 (control group; CG) and n=55 (inter-
vention group; IG)
c in % of 100 %
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A.4 SF-36 QoL ITT study data compared to a healthy
reference population
Table A.4: SF-36 baseline data and reference valuesb
Scalea Groupc Meanc Groupd Signifi-d Varianced
(SD) cance lower
bound
upper
bound
SF-36 PF CG 23 (24) IG 0.789 -13.18 7.47
NG 0.001 -68.06 -53.06
IG 26 (24) CG 0.789 -7.47 13.18
NG 0.001 -65.13 -50.28
NG 84 (24) CG 0.001 53.06 68.06
IG 0.001 50.2779 65.13
SF-36 RP CG 4 (9) IG 0.230 -12.62 2.3
NG 0.001 -80.19 -73.79
IG 9 (23) CG 0.230 -2.3 12.62
NG 0.001 -78.79 80.19
NG 81 (35) CG 0.001 73.79 80.19
IG 0.001 64.73 78.93
SF-36 BP CG 50 (34) IG 0.262 -4.93 24.26
NG 0.001 -37.80 -15.94
IG 41 (33) CG 0.262 -24.26 4.93
NG 0.001 -46.63 -26.44
NG 77 (28) CG 0.001 15.94 37.80
IG 0.001 26.44 46.63
SF-36 GH CG 48 (20) IG 0.89 -10.35 6.99
NG 0.89 -24.76 -11.60
IG 50 (19) CG 0.89 -6.99 10.35
NG 0.001 -22.45 -10.55
NG 66 (21) CG 0.001 11.60 24.76
IG 0.001 10.55 22.45
SF-36 VT CG 25 (18) IG 0.524 -4.33 11.63
NG 0.001 -42.68 -30.82
IG 21 (18) CG 0.524 -11.63 4.33
NG 0.001 -46.01 -34.80
NG 62 (19) CG 0.001 30.82 42.68
IG 0.001 34.80 46.01
continued
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Table A.4: SF-36 baseline data and reference values (cont.)
Scalea Groupc Meanc Groupd Signifi-d Varianced
(SD) cance lower
bound
upper
bound
SF-36 SF CG 67 (32) IG 0.285 -4.90 22.36
NG 0.001 -31.26 -10.74
IG 58 (31) CG 0.285 -22.36 4.90
NG 0.001 -39.04 -20.42
NG 88 (19) CG 0.001 10.74 31.26
IG 0.001 20.42 39.04
SF-36 RE CG 52 (48) IG 0.932 -17.94 24.28
NG 0.001 -50.84 -19.89
IG 49 (49) CG 0.932 -24.28 17.94
NG 0.001 -53.40 -2.68
NG 88 (29) CG 0.001 19.89 50.84
IG 0.001 23.68 53.40
SF-36 MH CG 63 (17) IG 0.207 -2.30 14.05
NG 0.001 -15.36 -4.48
IG 57 (21) CG 0.207 -14.05 2.30
NG 0.001 -22.12 -9.45
NG 73 (17) CG 0.001 4.48 15.36
IG 0.001 9.47 22.12
SF-36 PCS CG 27 (7) IG 0.797 -4.09 2.35
NG 0.001 -24.65 -20.10
IG 28 (8) CG 0.797 -2.35 4.09
NG 0.001 -23.93 -19.07
NG 49 (11) CG 0.001 20.10 24.65
IG 0.001 19.07 23.93
SF-36 MCS CG 47 (11) IG 0.231 -1.53 8.47
NG 0.029 -7.56 -0.33
IG 44 (12) CG 0.231 -8.47 1.53
NG 0.001 -11.0 -3.82
NG 51 (9) CG 0.029 0.33 7.56
IG 0.001 3.82 11.0
a SF-36 subscales: PF-Physical Function, GH-General Health, RP-Role Physical,
BP-Bodily Pain, SF-Social function, RE-Role emotional, MH-Mental Health, VT-
Vitality, PCS-Physical Component Summary, MCS-Mental Component Summary
b for all SF-36 sub- and summary scales: n=56 (Control Group; CG), n=63 (Inter-
vention Group; IG) and n=2861 (Norm Population; NG)
c ANalysis Of VAriance, values in %
d post-hoc tests
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A.5.1 Baseline data
Table A.5: Baseline data
Variable Randomi-
sation
Mean (SD) Median (min-max) Variance Signifi-
cance
Age CG1 76 (10) 76 (43-94) 108 0.206
IG2 71 (16) 75 (21-94) 262
Heigth CG 165 (10) 164 (147-192) 101 0.375
IG 166 (8) 166 (148-190) 69
Body weight CG 66.0 (16.2) 65.9 (29.6-99.0) 260.9 0.465
Admission IG 68.2 (16.6) 67.7 (39.7-119.0) 276.8
Vit C serum CG 26.8 (20.2) 22.5 (1.0-92.7) 407.9 0.109
concentration IG 33.1 (21.9) 27.9 (1.6-96.0) 481.6
Vit D serum CG 44.9 (25.8) 35.5 (13.2-128.9) 665.1 0.121
concentration IG 52.1 (24.3) 47.7 (14.6-134.9) 589.3
Glutathion serum CG 3.73 (2.06) 3.58 (0.36-9.00) 4.25 0.499
concentration IG 4.08 (2.44) 4.04 (0.32-14.99) 5.97
NRS-2002 CG 1.1 (0.3) 1.0 (0-2.0) 0.1 0.011
disease score IG 0.9 (0.5) 1.0 (0-2.0) 0.2
NRS-2002 CG 1.7 (0.7) 2 (0-3) 0.5 0.244
nutrition score IG 1.8 (0.6) 2 (1-3) 0.4
Number CG 7 (3) 7 (1-12) 7 0.476
oral drugs IG 7 (3) 6 (1-14) 9
REE3 CG 1339 (205) 1295 (970-1785) 41958 0.554
IG 1361 (188) 1331 (1068-1768) 35456
Sum of SF4 CG 1.3 (0.1) 1.3 (1.2-1.4) 0.0 0.250
and PAL5 IG 1.3 (0.7) 1.3 (1.1-1.4) 0.0
continued
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Table A.5: Baseline data (cont.)
Variable Randomi-
sation
Mean (SD) Median (min-max) Variance Signifi-
cance
TEE6 CG 1717 (251) 1684 (1272-2321) 63091 0.800
IG 1728 (230) 1714 (1348-2211) 52982
1 Control Group
2 Intervention Group
3 Resting Energy Expenditure
4 Stress Factor
5 Physical Activity Level
6 Total Energy Expenditure
Table A.6: Diagnoses according to ICD-103 coding
ICD-10 code Randomisation Frequency
Infectious and parasitic CG1 9
diseases IG2 4
Neoplasms, diseases CG 14
of the blood IG 10
Endocrine and metabolic diseases, CG 9
diseases of the digestive system IG 9
Diseases of the nervous system, CG 2
the eye and adnexa IG 5
Diseases of the CG 14
circulatory system IG 15
Others CG 11
IG 16
1 Control Group
2 Intervention Group
3 International Classification of Diseases (10th edition)
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Table A.7: SF-36 baseline data per protocolb
Scalea Randomi-
sation
Mean (SD)c Medianc
(min-max)
Variance Signifi-
cance
SF-36 PF CG1 23 (24) 15 (0-85) 577 0.642
IG2 25 (24) 20 (0-95) 583
SF-36 RP CG 3 (9) 0 (0-25) 73 0.081
IG 9 (24) 0 (0-100) 581
SF-36 BP CG 50 (34) 41 (0-100) 1159 0.225
IG 42 (35) 32 (0-100) 1194
SF-36 GH CG 49 (20) 47 (15-95) 401 0.689
IG 51 (19) 52 (10-100) 369
SF-36 VT CG 25 (19) 25 (0-75) 347 0.362
IG 22 (19) 18 (0-90) 363
SF-36 SF CG 68 (32) 75 (0-100) 1030 0.105
IG 58 (32) 63 (0-100) 1049
SF-36 RE CG 53 (48) 67 (0-100) 2279 0.759
IG 51 (49) 50 (0-100) 2424
SF-36 MH CG 63 (17) 60 (28-100) 287 0.252
IG 59 (20) 56 (16-100) 410
SF-36 PCS CG 27 (7) 26 (10-42) 49 0.626
IG 27 (8) 28 (10-47) 67
SF-36 MCS CG 48 (11) 46 (25-69) 122 0.160
IG 44 (12) 44 (24-66) 146
a SF-36 abbreviations: PF-Physical Function, GH-General Health, RP-Role Physi-
cal, BP-Bodily Pain, SF-Social function, RE-Role emotional, MH-Mental Health,
VT-Vitality, PCS-Physical Component Summary, MCS-Mental Component Sum-
mary
b for all SF-36 sub- and summary scales: n=54 (CG) and n=56 (IG)
c in %
1 Control Group
2 Intervention Group
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A.5.2 Results of the intervention
Table A.8: Intervention resultsb
Variable Randomi-
sation
Mean (SD) Median (min-max) Variance Signifi-
cancea
Kcal/d CG1 1127 (345) 1152 (485-2082) 118893 <0.001
IG2 1593 (332) 1583 (920-2827) 110246
Protein/d CG 44.6 (15.5) 44.9 (16.4-103.8) 241.3 <0.001
IG 67.5 (15.8) 67.6 (32.4-102.2) 250.9
a Repeated measure ANalysis Of VAriance
b Intervention periods 5 and 10 days (with n=59 and n=34, respectively)
1 Control Group
2 Intervention Group
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Table A.9: Caloric intake per meal and therapeutic approach
Variable Randomi-
sation
Mean
(SD)
MD (min-max) Variance Significance
Breakfast CG1 354 (145) 359 (99-676) 20939 0.782
IG2 362 (114) 348 (138-754) 13001
Morning CG 39 (55) 13 (0-304) 2992 <0.001
snack IG 119 (59) 106 (20-295) 3540
Lunch CG 283 (101) 278 (98-495) 10172 <0.001
IG 368 (96) 377 (111-573) 9186
Afternoon CG 57 (64) 42 (0-250) 4075 <0.001
snack IG 183 (64) 174 (52-394) 4090
Supper CG 341 (114) 348 (111-647) 12890 0.012
IG 396 (111) 408 (151-640) 12287
Bedtime CG 33 (51) 9 (0-250) 2551 <0.001
snack IG 139 (71) 157 (1-325) 5072
Enteral CG 2 (12) 0 (0-94) 149 0.547
nutrition IG 19 (127) 0 (0-964) 16199
Fortification CG 2 (5) 0 (20) 24 <0.001
IG 63 (40) 56 (1-202) 1607
ONS3 CG 27 (117) 0 (0-750) 13606 <0.001
IG 141 (121) 120 (0-546) 14729
Intravenous CG 18 (44) 0 (0-291) 1966 0.050
supply IG 6 (17) 0 (0-106) 299
1 Control Group
2 Intervention Group
3 Oral Nutritional Supplements
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Table A.10: Protein intake per meal and therapeutic approach
Variable Randomi-
sation
Mean
(SD)
MD (min-max) Variance Significance
Breakfast CG1 10.2 (4.4) 9.7 (2.1-24.3) 19.4 0.853
IG2 10.3 (3.9) 9.2 (3.4-17.1) 15.2
Morning CG 1.2 (2.8) 0.3 (0.0-19.8) 7.9 <0.001
snack IG 4.4 (3.4) 3.2 (0.1-14.0) 11.9
Lunch CG 14.8 (6.1) 13.9 (4.1-31.5) 37.6 <0.001
IG 19.8 (6.5) 20.0 (6.0-38.3) 42.1
Afternoon CG 1.7 (3.3) 0.7 (0.0-18.8) 11.1 <0.001
snack IG 6.5 (2.9) 5.7 (1.4-14.0) 8.3
Supper CG 15.2 (4.8) 15.6 (4.4-27.6) 23.1 0.006
IG 18.0 (5.8) 18.4 (5.7-30.6) 33.8
Bedtime CG 1.4 (2.9) 0.1 (0.-18.8) 8.4 <0.001
snack IG 7.7 (4.9) 7.1 (0.0-20.8) 24.2
Enteral CG 0.1 (0.5) 0 (0-3.8) 0.2 0.547
nutrition IG 0.8 (5.1) 0 (0-38.6) 25.9
Fortification CG 0.3 (0.9) 0.0 (0.0-4.8) 0.8 <0.001
IG 2.8 (2.1) 2.4 (0.1-9.8) 4.5
ONS3 CG 1.9 (8.3) 0.0 (0.0-56.4) 68.4 <0.001
IG 9.4 (7.6) 6.6 (0.0-25.6 57.3
Intravenous CG substrates did not contain
supply IG any proteins
1 Control Group
2 Intervention Group
3 Oral Nutritional Supplements
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A.5.3 Outcome data
Table A.11: Further outcome data
Variable Randomi-
sation
Mean (SD) MD (min-max) Variance Signifi-
cance
LOSe CG1 14.3 (9.6) 13 (4-62) 92 0.432
IG2 13.1 (6.4) 11 (5-38) 41
LOSf CG 15.4 (10.1) 13 (4-62) 102 0.954
IG 15.3 (8.8) 13 (5-41) 77
LOSg CG 16.1 (10.2) 13 (6-63) 104 0.393
IG 14.7 (6.9) 13 (6-38) 48
LOSh CG 17.2 (10.6) 14 (6-63) 112 0.874
IG 16.9 (9.0) 15 (6-42) 81
LOSi CG 20.1 (17.5) 15 (7-120) 305 0.492
IG 18.3 (10.2) 16 (6-48) 104
Body weight CG 64.4 (15.8) 62.2 (29.6-99.9) 251 0.185
discharge IG 68.3 (15.5) 66.2 (41.6-109.9) 240
Difference CG -1.5 (3.0) -1.4 (-9.1-4.8) 8.8 0.003
body weight IG 0.1 (2.8) 0.0 (-6.5-7.4) 7.6
BMI3 CG 23.6 (4.9) 23.6 (13.2-42.7) 24.5 0.249
IG 24.7 (4.8) 24.8 (16.3-36.7) 23.3
e Study inclusion to possible discharge
f Study inclusion to definite discharge
g Ward admission to possible discharge
h Ward admission to definite discharge
i Hospital admission to discharge
1 Control Group
2 Intervention Group
3 Body Mass Index
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Table A.12: SF-36 outcome datab
Scalea Randomi-
sation
Mean (SD)c Median
(min-max)c
Variance Signifi-
cance
SF-36 PF CG1 38 (27) 35 (090) 745 0.016
IG2 51 (26) 53 (0-100) 686
SF-36 RP CG 19 (36) 0 (0-100) 1283 0.075
IG 33 (41) 0 (0-100) 1693
SF-36 BP CG 69 (29) 73 (0-100) 858 0.598
IG 65 (33) 73 (0-100) 1102
SF-36 GH CG 54 (17) 56 (10-92) 303 0.123
IG 59 (22) 67 (15-97) 481
SF-36 VT CG 40 (18) 35 (5-85) 307 0.821
IG 41 (23) 40 (0-90) 550
SF-36 SF CG 80 (23) 88 (25-100) 524 0.736
IG 79 (25) 88 (0-100) 647
SF-36 RE CG 67 (44) 100 (0-100) 1944 0.458
IG 73 (43) 100 (0-100) 1889
SF-36 MH CG 71 (19) 76 (12-100) 350 0.894
IG 71 (19) 72 (24-100) 359
SF-36 PCS CG 33 (9) 30 (19-56) 74 0.037
IG 37 (11) 35 (15-65) 117
SF-36 MCS CG 52 (11) 53 (22-72) 118 0.597
IG 51 (11) 52 (25-66) 111
a SF-36 abbreviations: PF-Physical Function, GH-General Health, RP-Role Physi-
cal, BP-Bodily Pain, SF-Social function, RE-Role emotional, MH-Mental Health,
VT-Vitality, PCS-Physical Component Summary, MCS-Mental Component Sum-
mary
b for all SF-36 sub- and summary scales: n=50 (CG) and n=58 (IG)
c in %
1 Control Group
2 Intervention Group
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Closing remarks
A preface opens this thesis. Thus closing remarks will complete it but is there anymore
to say? Every detail of the study was explained; the results were reported and discussed.
And still, it feels incompleted without some rather subjective thoughts on the topic.
This study provided promising results related to nutritional support in hospitalised
patients. Indeed, the results exceeded my expectations. Still, put in the context of
Evidenced Based Medicine (EBM) they are of rather low quality due to soft outcome
measures and a low number of patients. This is, however, a common challenge of nutri-
tion trials (see discussion). The question is whether hard outcome multicentre nutrition
trials can be performed successfully at all? One of the most famous scientists, Albert
Einstein, stated what well fits to the problem of nutrition and food:
Not everything that can be counted counts and not everything that counts
can be counted.
Like in other studies investigating ”services”, the efficiency of intervention is related
to the person doing the intervention, the heterogenity of the setting and the complexity
of the intervention - much more than in a pharmaceutical trial that applies a pill. EBM
is necessary to describe a drug and its effectiveness and safeness exactly. Of course, if
normal food is supposed to be a treatment, then it underlies EBM as well. On the other
hand, do we need evidence to emphasize on the importance of eating? And conversely,
should one disregard food and eating during disease merely because an increase of sur-
vival rate has not been shown so far? Probably, the way how health care is provided
influences the nutritional status of patients more than the missing evidence. Then, the
phenomenon called disease-related malnutrition appears at least partly due to a lack of
quality of care. If a hospital or ward works well, provides high quality care, has suffi-
cient nurse-patients quotients etc., then malnutrition may occur less often. Malnutrition
prevalence/incidence would then become an indicator for general quality of disease treat-
ment and patient care. The relation of readmission rates and the quality of in-hospital
care has been addressed [320]. A good nutritional management then probably leads to
fewer readmissions (and not simply less cases) or fewer complications (and not simply
patients with lower case-mix-index). However, a better quality of care can hardly be
achieved as long as LOS is the outcome parameter of first choice. Then, discharging
patients at all costs determines health care procedures, i.e. first of all diagnostics. So
the treatments may be received in the ambulant setting where the revenues exceed the
inpatient costs of the same treatment many times over.
Also, new and more invasive diagnostics and treatments influence the nutritional status
beside the quality of care. They require special conditions which are unfavourable for
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the nutritional status (see Introduction). Thus, if a comprised nutritional status is
related to a bad outcome, than benefits related to the new disease treatment must
be weight against its harms. If furthermore a treatment worsens the patient’s QoL
substantively, than - although a statistical difference in the outcome may have been
reported (in concordance with EBM) - the patients should define what a benefit is to
them. Additionally, patients should ask their doctors more often ”How do you know?”. It
was the Swiss author and dramatist, Friedrich Du¨rrenmatt, who perfectly presented this
challenge of science in the play ”Die Physiker”: if it is too difficult to handle a promising
intervention safely, then hands away! New inventions in the health care system may
not threaten world life in total but may be detrimental for the patients. In contrast,
there may be few patients where the treatment helps perfectly. This issue is tackled
by the recently upcoming ”personalised medicine” [321]. The majority of patients may,
however, profit from ”personalised medicine” in the literal sense - a more human, patient-
centred care. Then, less often is more [322]. Additionally, the costs of new inventions
produce an increasing burden for the health care system and thus future generations. The
former prime minister of Saxony, Prof. Kurt Biedenkopf, demanded once a reasonable
and modest use of resources in order to fulfil the intergenerational contract [323]. Can
we disregard the very basis of life (i.e. eating) while offering expensive treatments
lengthening the ”relapse free time” (and not even the lifespan) by a few months of a low
quality of life? Is there anybody who wants this even if costs are refunded?
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